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THE KNOWLEDGE OF ACUTE CARE NURSES 
REGARDING ACUTE CORONARY SYNDROMES 
SUMMARY 
The term Acute Coronary Syndrome (ACS) encompasses a spectrum of patients who 
present with chest discomfort or other symptoms caused by myocardial ischemia or 
infarction. Since critical or acute care nurses care for such patients, they should have a 
thorough knowledge of ACS pathophysiology and current treatments for ACS 
The purpose of this research study is to explore and describe the knowledge level that the 
critical care nurses in a state hospital in East Texas feel they have regarding ACS. This 
study was quantitative, descriptive and contextual in design, in which a sample survey 
was performed, using a questionnaire based on a literature study. 
The response of most ofthe critical care nurses tested was that they felt they had 
insufficient knowledge. An in-service training session has been proposed to help 
improve the nurses' knowledge and expertise on ACS. 
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CHAPTER 1 
OVERVIEW OF STUDY 
1.1 INTRODUCTION 
Acute coronary syndromes (ACS) -unstable angina, non-Q-wave myocardial 
infarction (MI), and Q-wave MI - all share the physiological feature of thrombosis due to 
disruption of atherosclerotic plaque. Advances in understanding ofthe pathophysiology 
' of ACS have led to the development of new therapeutic agents and treatment strategies 
that hold promise for better clinical outcomes. 
Patients with life-threatening acute myocardial infarctions have been the main focus of 
traditional chest pain protocols. That is because they require immediate treatment to stop 
the infarction, usually with thrombolytics and angioplasty, atherectomy, or intracoronary 
stenting. This emphasis on immediate care for the acute MI patient puts patients who 
. might be at long-term risk for developing an MI in the background, which means they 
may receive less aggressive treatment, or no treatment at all. ACS encompasses not only 
acute MI patients, but also subsets ofhigh-risk patients who need aggressive treatment to 
prevent an MI (Sieck 2000: 5). 
An acute MI is a full-thickness injury to the myocardial tissue, demonstrated on ECG by 
ST segment elevation. A non-Q wave MI suggests that plaque or a thrombus is just 
beginning to reach critical form in the vessel wall, and is denoted by ST segment 
depression on ECG. In these patients, the ST segment could flip up as blockage develops 
into a full-thickness injury. Unstable angina, depicted by ST segment depression or T-
wave inversion on ECG, can develop because of plaque, a small thrombus or arterial 
spasms. 
In the past decade, considerable progress has been made in treatment of the ST segment 
elevation population, and we now have a number of established therapies for this 
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population, including reperfusion therapy, anti-platelet therapy, as well as the use ofbeta-
blockers, ACE inhibitors, and lipid-lowering therapy. As critical care nurses have 
increased their knowledge and expertise of such therapies, they have become more 
comfortable in providing nursing care for ACS patients. In contrast, the non-ST segment 
elevation population is more diverse and the severity of ischemic heart disease is more 
difficult to establish at the time of presentation. New approaches in the treatment of 
unstable angina and non-Q-wave MI include the use of new cardiac markers for 
diagnosis, glycoprotein lib/lila inhibitor agents as an adjunctive therapy with 
percutaneous coronary intervention (PCI) or alone as medical therapy, and low molecular 
weight heparins (LMWH). Because many of these new approaches to treating unstable 
angina and non-Q-wave MI are not yet firmly established, some critical or acute care 
nurses may find themselves in the middle of a steep learning curve. As they increase 
their knowledge and expertise in these areas, they will achieve a greater familiarity with 
the nursing care required for such patients. 
In addition to being familiar with current approaches to treating ACS, a thorough 
knowledge of the pathophysiology of ACS is vital if the nurse is to understand the 
rationale behind approaches for treating ACS. This begins with the very beginnings of 
ACS - atherosclerosis, endothelial damage, the clotting cascade, and the formation and 
rupture of thrombi and plaque (Gylys & Gold 2000: 3-13; Sieck 2000: 5-6). Critical or 
acute care nurses must know the pathophysiology of coronary artery disease (CAD) and 
understand the rapidly evolving treatment options for ACS in order to provide highly 
skilled and knowledgeable critical nursing care and be able to answer questions and 
provide guidance to their patients and other members of the healthcare team. 
1.2 RESEARCH PROBLEM 
Acute Coronary Syndromes (ACS) is a term that has been coined over the past decade 
which encompasses unstable angina, non-Q-wave Ml and Q-wave MI. Although the 
disease processes themselves are not new, advances have been made in understanding the 
causes and in treatment options. 
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Cardiovascular intensive care nursing has been of great interest to the researcher for 
many years, but what sparked interest in this study was comments made by some very 
experienced intensive care nurses during a conversation one day where it became clear 
that they did not know the difference between a non-Q-wave and a Q-wave MI. 
Likewise, the definition of ACS was not known. This surprised the researcher, because 
these nurses had extensive I CU nursing experience and regularly cared for cardiac 
patients with MI's and open-heart surgery. 
The problem then that emerged is that it seems as if nurses working in the critical or 
acute care units lack knowledge about ACS. 
1.3 SIGNIFICANCE OF THE STUDY 
This research study is significant to the critical or acute care nurse population in general 
because it stresses the need for such nurses to be knowledgeable about the conditions of 
their patients. This study revealed a perceived knowledge deficit about ACS in a sample 
population of critical or acute care nurses and subsequently provided a comprehensible 
in-service training session on ACS. The researcher believes that in order to provide 
quality nursing care for patients who fall in the ACS continuum, the nurse should have a 
thorough knowledge of the disease process of ACS, treatments and medications currently 
available and their rationales for use. She should also be able to explain these in a clear 
and simple manner comprehensible to their patients. Understanding the pathophysiology 
of ACS begins with the beginnings of ACS - atherosclerosis, endothelial damage, the 
clotting cascade, and the formation and rupture of thrombi and plaque (Ryan 2000: 5-6; 
Gylys & Gold 2000: 3-13). A thorough knowledge ofthe disease process of coronary 
artery disease (CAD) provides a basis for comprehending the rapidly evolving treatment 
options for ACS. It helps the nurse provide highly skilled and knowledgeable critical 
nursing care and be able to answer questions and provide guidance to their patients and 
other members of the healthcare team. It also behooves the critical care nurse to have 
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some knowledge of current research about ACS and possible treatments available in the 
future. 
The researcher noted during her literature study that the majority of information on ACS 
was found in medical journals for physicians, although a small number of articles were 
found in nursing publications. In addition to numerous medical journal publications and 
several nursing journal publications (see bibliography), the researcher found two books to 
be immensely comprehensive and informative on the subject of ACS: Acute Coronary 
Syndromes, edited by EJ T opal, is an excellent source which covers detailed 
pathophysiology of ACS: pre-, in- and post-hospital treatment of unstable angina, non-Q-
wave MI and Q-wave Ml; cardiac markers; chest pain control centers; includes an 
explanation of the GUSTO Trials; stenting and angioplasty; plaque stabilization; and 
future possible therapies for treating ACS. Cardiovascular Trials Review editors, RA 
Kloner and Y Birnbaum, give short one to two page reviews on cardiovascular trials, 
many of which deal with acute MI, unstable angina, coronary artery disease, 
atherosclerosis and the prevention of it~ progression, and other related topics. 
1.4 OBJECTIVES 
The objectives of this research study were: 
0 to explore and describe the critical care nurse's knowledge according to their own 
rating regarding the pathophysiology of ACS and current treatments available 
0 to use the information obtained to formulate a four hour in-service training 
session for critical care nurses about ACS and current treatments 
1.5 ASSUMPTIONS OF THIS STUDY 
Critical thinking is imperative to the nursing process. This is the underlying philosophy 
driving this research. Smeltzer & Bare (2000:23) defines critical thinking as follows: 
5 
"Critical thinking is a cognitive or mental process that involves conscious, systematic, 
reflective, rational, and goal-oriented examination and analysis of all available 
information and ideas and the formation of conclusions and the most appropriate, often 
creative decisions." Independent judgments and decisions arise from a sound knowledge 
base and the ability to integrate information within the context in which it is gathered. 
Nursing practice today - especially critical care nursing - must involve the use of high-
level critical thinking skills within the nursing process. Critical thinking is imperative to 
clinical decision making, helping to identify patient needs and to decide which nursing 
actions will help the patient in meeting those needs. 
The nursing process is a method for making decisions. It is a way of thinking and acting 
in relation to the clinical phenomena of concern to nurses. Classically, it comprises five 
phases or dimensions: nursing assessment, nursing diagnosis, planning, implementation 
and evaluation. The nursing process is a way of solving clinical problems, but it is more 
than just a problem-solving method. It is a way of thinking, and unlike a problem-solving 
method, the nursing process is continuous, not episodic. 
The five phases of the nursing process represent a continuous cycle throughout the 
nurse's moment-to-moment data interpretation and management of patient care. This 
process is also interactive, i.e. all the phases operate and influence each other and the 
patient simultaneously. Such a systematic method for approaching, analyzing and 
managing clinical problems is invaluable because it leads to sound decisions (Thelan, 
Davie, Urden & Lough 1994: 3-4). The two diagrams in Figure 1.1 illustrate the cyclical 
and interactive nature of the nursing process. 
Figure 1.1 Cyclical and interactive nature of the nursing process 
nursing 
\ 
implementation planning 
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Critical or acute care nurses are highly specialized nurses, and the researcher assumes 
that they have a solid knowledge of critical care nursing in order to provide the skilled 
and competent intensive care for patients whose condition may change rapidly and who 
require both close monitoring and critical care intervention. The nurse is responsible for 
maintaining competence by continual learning, education and in-service training. The 
nurse is responsible for the patient to whom he/she has been assigned, and is accountable 
for his/her actions and omissions. It is therefore assumed that the critical or acute care 
nurse should have a thorough and relevant knowledge and competency regarding the 
patients he/she cares for, including ACS where ACS patients are cared for. 
1.6 KEY TERMS AND CONCEPTS FOR THIS RESEARCH STUDY 
1.6.1 ACUTE CORONARY SYNDROMES 
ACS includes a continuum of patients presenting with chest pain or other symptoms 
caused by myocardial ischemia or infarction. ACS includes unstable angina, non-Q-
wave MI and Q-wave MI. 
1.6.2 ATHEROSCLEROSIS 
A generalized disease of the arteries characterized by focal changes in the intima of the 
large and medium-sized arteries. These changes consist ofthe accumulation of lipids, 
calcium, blood components, carbohydrates, and fibrous tissue (atheroma or plaque) on 
the intimal layer of the artery. Because atherosclerosis is a generalized disease of the 
arteries, when it is found in the extremeties, it is usually present elsewhere in the body 
(Smeltzer & Bare 2000: 749). 
1.6.3 CRITICAL OR ACUTE CARE NURSING 
In 1984, the American Association of Critical Care Nurses (AACN) defined critical or 
acute care nursing in this way: " ... the American Nurses' Association defines nursing as 
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the 'diagnosis and treatment of human responses to actual or potential health problems.' 
Critical care nursing is that specialty within nursing that deals specifically with human 
responses to life-threatening problems." (Hartshorn, Lamborn & Noll1993: 4) Critical 
or acute care nursing involves the care of highly unstable, highly at-risk patients whose 
health conditions may change minute by minute. Critical care or acute nurses are highly 
specialized nurses who have a solid understanding of critical care nursing and of relevant 
information from other sources. The term critical care nursing is exchangeable with the 
terms acute care nursing or intensive care nursing. In this study the term critical care 
nursing is used more often than the term acute care nursing, as in the literature the term 
critical care nursing is used more often. 
1.6.4 CRITICAL OR CARE ENVIRONMENT 
The critical care environment as defined for this research study is the areas of the hospital 
with specialized facilities and technology needed to care for critical care patients, 
including pre- and post -operative patients. The facilities include monitoring devices and 
resuscitation equipment. Staff members are physicians, both general practice and 
specialized; anesthesiologists; respiratory technicians; and critical care nurses with post-
registration qualifications or experience in critical care nursing. 
The critical care environment at the hospital where this study was performed includes the 
Intensive Care Unit (ICU), the Operating Room (OR), the Emergency Room (ER), the 
Cardiac Catheterization Laboratory (cath lab) and Telemetry (5 East). 
1.6.5 STABLE ANGINA 
Stable angina is chest pain caused by intermittent myocardial ischemia brought on by 
vasospasms of coronary arteries that may or may not be narrowed by atheroscloerotic 
plaque. Symptoms of stable angina are exacerbated by activity and relieved by rest and 
sublingual nitroglygerine. Angina pain differs between patients and has a characteristic 
pattern for each patient. Common descriptions of pain include squeezing, heaviness, or 
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burning in the chest; a pressure-like sensation or a feeling of strangulation or constriction 
around the chest. Some patients report that the pain radiates to the neck, jaw, left arm or 
between the shoulder blades. Some complain of nausea, headaches or dizziness. Section 
2.5.3 in Chapter 2 refers to what causes stable angina (McAvory 2000:34-36). 
1.6.6. UNSTABLE ANGINA 
Angina is considered "unstable" if symptoms occur unpredictably, or if previously stable 
symptoms become more intense, last longer, or radiate to a different location than usual. 
Unstable angina (UA) is not always caused by exertion- it can also occur during rest or 
sleep- and it is not always relieved by rest and NTG. It indicates severe coronary vessel 
narrowing from atherosclerotic plaque. Because atherosclerotic lesions are inflexible, 
they limit the vessels' ability to dilate in response to NTG. UA indicates severe coronary 
vessel narrowing from atherosclerotic plaque, a small thrombus or arterial spasms 
(McAvoy 2000: 34-39). Sections 2.5.3 and 2.8.1 refer to what causes unstable angina. 
1.6. 7 MYOCARDIAL ISCHEMIA 
This occurs where there is an insufficient supply of oxygen to the heart, usually related to 
coronary insufficiency, or decreased blood flow to the heart. On ECG, ST segment 
depression of 1 mm or more in two or more contiguous leads or T -wave inversion 
indicates myocardial ischemia. Contiguous leads reflect electrical activity in the same 
area of the myocardium. It is usually a reversible, transient event that is corrected when 
the blood and oxygen supply to the myocardium is restored. The ST segment and T-
wave changes occur during periods of ischemia and may be seen only when the patient is 
experiencing pain. If these changes occur despite treatment, continued ischemia can 
damage the myocardium, resulting in an injury pattern on the ECG. 
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1.6.8 MYOCARDIAL INJURY 
Myocardial injury ranges from an acute myocardial infarction (AMI) to minor 
myocardial damage. On ECG, elevation of the ST segment of 1 mm or more above the 
isoelectric line in two or more contiguous leads indicates myocardial injury. This 
indicates impaired blood flow through the coronary artery from vasospasms and probably 
thrombus development. ST segment elevation indicates an acute injury to the heart 
muscle and requires immediate treatment to reestablish blood flow to the myocardium 
before infarction (death) occurs. ST segment elevation typically develops into 
myocardial infarction (MI), but with rapid treatment, injury may be reversible. 
1.6.9 MYOCARDIAL INFARCTION (MI) 
Myocardial infarction, or cell death, is caused by prolonged interruption of myocardial 
perfusion. It is the destruction of enough cardiac tissue in order to cause clinical, 
electrical and/or biochemical changes in the body. Classic symptoms are crushing pain, 
squeezing pressure in the sternum with radiation to the left arm; diaphoresis; pallor; 
dyspnea; and nausea lasting 30 minutes or longer. The patient may describe this chest 
pain as the worst he has ever had and experience a sense of impending doom. Rest and 
NTG do not relieve symptoms ofMI. Sometimes the pain ofMI is not always 
excruciating. Many patients complain of a nagging sensation of heaviness, pressure or 
tightness. Other possible signs and symptoms ofMI include dyspnea as the main 
complaint, indigestion, epigastric discomfort, right-sided chest pain, fatigue, light-
headedness, back pain, and nausea and vomiting. Patients more likely to experience 
these symptoms instead of severe chest pain include women of any age and race, people 
with diabetes, and the elderly (McAvoy 2000:34-39; Dennison 1996: 1 07-117). 
1.6.10 Q-WAVE MI 
Also called a "transmural infarction", a Q-wave Ml affects all three layers of the 
myocardial wall: epicardium, myocardium, and endocardium. Q-wave Ml is associated 
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with complete coronary occlusion and infrequent coronary collaterals (Dewood 1988: 
36F-38F; Church 2000: 36-37). On ECG, there will beST segment elevation and may 
also be a pathologic or significant Q-wave which is greater than 0.04 seconds in width 
and 25% the height of the R-wave, which indicates the MI has already occurred. The Q-
wave may decrease in size over time following an Ml, but it will always be present in a 
12-lead ECG. 
1.6.11 NON-Q-WAVE MI 
This type ofMI does not affect all three layers and is more common with diabetics or 
those who have developed good collateral circulation. This type ofMI is more difficult 
to diagnose. A non-Q-wave MI suggests that plaque or a thrombus is just beginning to 
reach critical form in the vessel wall, denoted by ST depression on ECG. In these 
patients the ST segment could flip up as blockage develops into full thickness injury. 
Although non-Q-wave MI was originally considered to be less serious than Q-wave MI, 
subsequent investigations have shown that the incidence of death and recurrent MI is as 
great as that associated with Q-wave infarction (Dennison 1996:110; Statland 1996: 43-
51; McAvoy 2000: 34-39; DeWood 1988: 36F-38F; Sieck 2000: 4-8). 
1. 7 RESEARCH DESIGN AND METHOD 
1.7.1 DESIGN 
The design of this research study was a quantitative, descriptive and contextual study in 
which a questionnaire was used as instrument. The knowledge of critical care nurses was 
explored and described according to their own rating, with the goal being to plan a four 
hour in-service training session on ACS for all critical care nurses in a state hospital in 
East Texas. The aim of this in-service training session is to increase nurses' knowledge 
about ACS, which will improve their nursing care for ACS patients. 
II 
1.7.2 METHOD 
The research method is summarized in Table 1.1 and will be discussed in detail in 
Chapter 3. 
Table 1.1 Research Design and Method 
AIM DATA SAMPLING& VALIDITY & DATA 
GATHERING POPULATION RELIABILITY ANALYSIS 
Explore and Implementation Convenience Literature review, Descriptive and 
describe the of a sample of professional inferential 
respondents' questionnaire voluntary critical experts' critique, statistics. 
perceptions as to care nurses of all Cronbach's alpha 
how they rate qualifications, and factor 
their knowledge regardless of staff analysis. 
regarding aspects appointment, in a 
of ACS such as its state hospital in 
pathophysiology, East Texas. 
current available 
treatments, 
rationales for such 
treatments and 
nursing care and 
to formulate an 
in-service training 
session on ACS. 
1.8 SUMMARY 
Acute coronary syndromes: whether it is newly diagnosed unstable angina or an acute 
myocardial infarction, the goal of therapy is pain relief and the limitation of myocardial 
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ischemia and (when relevant) reinfarction. Treatment needs to be accurate, rapid and 
closely monitored. 
For the critical care nurse, this rapidly evolving field regarding ACS presents an 
informational challenge. Challenging as it may be, nevertheless a sound knowledge base 
about ACS - its pathophysiology and current approaches to treatment - are necessary if 
the critical care nurse is to make judgments and decisions, identify patient needs and 
determine the best nursing care for that patient. 
This research study explored and described the critical care nurses' knowledge according 
to their own rating regarding ACS, and the information obtained from the research study 
and the literature review will be used to formulate an in-service training session for the 
critical care nurses about ACS and current treatments. 
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CHAPTER2 
LITERATURE STUDY 
2.1 INTRODUCTION 
As stated in Chapter 1, nursing practice today - especially critical care nursing - must 
involve the use of high-level critical thinking skills within the nursing process. 
Independent judgments and decisions, which are one of the outcomes of the critical 
thinking process, arise from a sound knowledge base and the ability to integrate this 
knowledge within the context in which it is gathered. The following literature study 
serves as a background to this research study, but at the same time covers information 
that the researcher believes is important for critical care nurses to know in order to 
provide competent nursing care for acute coronary syndrome patients. 
2.2 DEFINITION OF ACUTE CORONARY SYNDROMES 
Acute Coronary Syndromes (ACS) encompasses a spectrum of patients who present 
with chest pain or other symptoms caused by myocardial ischemia or infarction. The 
unification ofthese symptoms of coronary artery disease under the term Acute Coronary 
Syndromes reflects the understanding that these symptoms are caused by a similar 
pathophysiology, characterized by erosion or rupture of athersclerotic plaque, leading to 
intravascular thrombosis and impaired myocardial blood supply (Gylys & Gold 2000: 3; 
Simoons, Boersma, Vandeerzwaan, Deckers 1999: 1-4). ACS includes subsets ofhigh-
risk patients- unstable angina, non-Q-wave Ml, and Q-wave MI- who need aggressive 
treatment to prevent a MI from occurring or prevent the reoccurrence of a MI if one has 
already occurred. 
The outcome of these patients, especially whether the myocardial ischemia recovers fully 
or results in minor or major myocardial necrosis, depends on several factors -- the 
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presence or absence of mechanical obstruction by the plaque and its contents; the amount 
and extent of thrombus formation; the oxygen demand of the heart; the extent and 
duration of ischemia; vascular tone; and the degree of collateral circulation (Jesse 1999: 
213-221). 
2.2.1 UNSTABLE ANGINA, NON-Q-WA VE MI, Q-WAVE MI 
The reader should refer to section 1.6, Key terms and concepts for this research study for 
definition of the subsets of ACS: unstable angina, non-Q-wave MI and Q-wave MI. 
2.3 THE CLOTTING CASCADE 
Understanding the processes of the clotting cascade is essential for comprehending the 
beginning stages of ACS and understanding when specific medications exert their effects. 
2.3.1 FACTORS TRIGGERING THE INITIATION OF THE CLOTTING 
PROCESS 
Clot formation occurs when the body initiates either the intrinsic or extrinsic pathway. 
When a blood vessel is lacerated or crushed from an outside source, the body initiates the 
extrinsic pathway to activate hemostasis. The vessel constricts to slow blood loss, and 
platelets adhere to the area and combine with collagen, the underlying connective tissue 
in the exposed epithelium (the layer of cells that forms a blood or lymphatic vessel's 
inmost lining, as well as that of the heart) of the damaged vessel, to form a temporary 
plug or clot over the area. When platelets combine with collagen, they stimulate platelet 
aggregation and the release of thromboplastin (also called ''tissue factor", found in the 
interstitial compartments), which activates the clotting cascade. 
In the intrinsic pathway, internal forces expose the blood to collagen fibers underlying 
the endothelium in the blood vessels. This exposure activates clotting factors, which 
likewise initiate the clotting cascade. Forces that initiate the intrinsic pathway include 
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venous stasis (blood pools in vessels, allowing clotting factors to reach levels high 
enough to initiate clotting), diseases associated with hypercoagulability, and internal 
vessel disruption or injury. Vessel disruption or injury can occur spontaneously, such as 
in the disruption or erosion of athersclerotic plaque, oxidation oflow density lipoprotein 
(LDL) cholesterol which causes punctures in the endothelium. high shear stress resulting 
from hypertension, or sharp bends in the vessels, or it can occur as a result of 
percutaneous cornary intervention, known as PCI (Church 2000: 37; Fuster, Fayad & 
Badimon 1999: 5-9). 
Whether intrinsic or extrinsic, the pathway results in prothrombin activator. In the 
presence of calcium. this activator converts prothrombin to thrombin. Thrombin then 
converts plasma fibrinogen to fibrin threads that surround the blood cells and platelets 
at the iJ:Uury site, forming a clot, or thrombus. When thrombin is released, it also 
stimulates the production of fibrin-stabilizing factor, which increases the strength and 
effectiveness of the fibrin threads around the clot. Figure 2.1 on page 16 is a schematic 
representation of these basic steps in cJot formation, as drawn by this author. 
2.3.2 PLATELET AGGREGATION AND PLATELET PLUG FORMATION 
Platelets have a propensity for adhering to surfaces, but they do not adhere to normal 
endothelial cells lining blood vessels. Injury to a vessel disrupts the endothelium and 
exposes the underlying connective tissue collagen molecules. An adhesive plasma 
protein called von Willebrand factor (vWF), secreted by the endothelial cells, binds to 
collagen, and then platelets bind to it, forming an initial hemostatic plug. 
The initial platelet adherence to collagen triggers the platelets to release the contents of 
their secretory vesicles which contain a variety of chemical agents, one of which is ADP 
(adenosine diphosphate). When platelets are activated by agents such as collagen, 
thrombin or ADP, they change shape, causing new platelets to adhere to old ones. When 
platelets are activated and change shape, glycoprotein lib/lila receptors on the 
16 
Figure 2.1 Understanding clot formation and lysis 
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platelets' surfaces are activated to become receptors for adhesive plasma proteins, 
primarily soluble fibrinogen and vWF. Fibrinogen and vWF bind with these receptors, 
causing platelet aggregation. This cross-linking of activated GP Ilblllla receptors on 
adjacent platelets by adhesive plasma proteins is the final common pathway to platelet 
aggregation and vascular thrombosis. On unstimulated, normal shaped discoid platelets, 
GP IIb/IIIb receptors are unable to bind to fibrinogen. Figure 2.2, redrawn by this 
author, diagrams this process (Harrington 1999: S277). 
Figure 2.2 Cross-linking of activated GP Jlblllla receptors on platelets 
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platelet adherence to collagen causes the conversion of arachidonic acid in the platelet 
plasma membrane to thromboxane A2, which powerfully stimulates platelet aggregation 
and secretion of platelet granules, helping to further along thrombus formation. 
In summary, the platelet plug is built up extremely rapidly and is the main sealer of 
breaks in the vessel wall. When the platelets are exposed to collagen and other 
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substances, they are activated, change shape, and their GP Ilblllla receptors bind with 
soluble fibrinogen causing platelet aggregation. Platelet aggregation is necessary for the 
next hemostatic event - blood coagulation and thrombus formation (Harrington 1999: 
S276-S285; MacCallum, Hanlon & Byrne 1999: 34-39; Vander, Sherman & Luciano: 
1990: 689-695). 
2.3.3 THE CLOTTING CASCADE AND THROMBUS FORMATION 
Blood coagulation, or clotting, is a transformation ofblood into a solid gel called a clot, 
or thrombus. Clotting is the dominant hemostatic defense. It occurs around the initial 
platelet plug, when the plasma protein fibrinogen is converted to fibrin. The function of 
the clot is to support and reinforce the platelet plug and to solidify the blood that remains 
in the wound channel. 
Prothrombin, an inactive precursor of thrombin, circulates in the blood continuously. 
At the site ofvessel damage, prothrombin is converted to thrombin. Thrombin 
catalyzes a reaction which causes fibrinogen, a large rod-shaped protein produced by the 
liver and always present in the plasma of a normal person. to be converted to fibrin. As 
mentioned above, soluble fibrinogen first binds with activated GP Ilblllla receptors on 
the platelets' surfaces. Initially fibrin is a loose mesh of interlacing strands, but rapidly 
becomes stabilized and strengthened. This stabilizing process of loose fibrin is catalyzed 
by an enzyme in plasma known as factor XIII, which is converted from inactive form to 
active form (XIIIa) by thrombin. Thus thrombin catalyzes the formation of fibrin and 
the active factor XIII, which will stabilize the fibrin network. 
In the process of clotting, erythrocytes and other cells are caught in the fibrin meshwork, 
but the main components ofthe clot are fibrin and platelets, and clotting can occur in the 
absence of all cells except platelets. 
The enzyme that catalyzes the conversion of prothrombin to thrombin is always present 
in plasma in its inactive form, and is converted to its active form by another enzyme. In 
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other words, there is a cascade of plasma proteins, each one normally an inactive 
proteolytic enzyme until it is activated by the previous one in the sequence. The first 
factor in the sequence is called factor XII. The question is -- what activates factor XII? 
When factor XII has contact with a damaged vessel surface, specifically with collagen 
fibers underlying damaged endothelium, then inactive XII is converted to active XII 
(XIIa) and thus the clotting cascade begins. 
Two of the circulating clotting factors, VIII and V, do not form actual links in the 
clotting cascade. They work as cofactors in two of the cascade reactions along with PF3, 
and their activation is stimulated by thrombin. PF3 is a phospholipid exposed in the 
plasma membranes of the aggregated platelets. 
Figure 2.3 on page 20 is a diagram of the intrinsic clotting pathway, redrawn by the 
author (Vander et all990: 693). Thrombin profoundly stimulates platelet aggregation, in 
addition to its three other functions (stimulates the activation of factors V, VII and PF3: 
converts fibrinogen to fibrin; and converts inactive factor XIII to active factor XIII which 
then stabilizes the fibrin meshwork). Thus, once thrombin formation has begun, the 
overall reactions leading to clotting occur rapidly, due to the positive feedback effects of 
thrombin. 
Thus we see that when the epithelial lining of a blood vessel is damaged, thereby 
exposing its underlying collagen layer, both platelet aggregation and the clotting cascade 
are activated, leading to the formation of a blood clot, or thrombus. The degree and 
duration ofthe thrombotic insult are major determinants of the clinical presentation of 
ACS. For example, persistent ST -segment elevation, usually accompanied by elevation 
of cardiac markers, is indicative of complete and prolonged ischemia distal to the 
occlusion. In patients without persistent ST -segment elevation but with other ECG 
(transient ST-segment elevation, ST-segment depression, T-wave inversion) or 
biochemical (elevation of cardiac markers) abnormalities suggestive of cardiac origin of 
chest pain, myocardial ischemia is of more limited duration and it is usually caused by 
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Figure 2.3 Intrisic Clotting Pathway 
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partially occlusive thrombi (Church 2000: 34-42; Harrington 1999: S276-S285; Gylys & 
Gold 2000: 3-13; Breen 2000: 59-62; Vander et al 1990: 690-694). 
2.3.4 PHARMACOLOGIC AGENTS INTERFERING WITH THROMBUS 
FORMATION 
It is important that the nurse have a thorough understanding of the pharmacologic agents 
used to treat ACS, including the drugs' actions, side effects, contraindications and 
rationales for use. Such knowledge enables the nurse to provide competent critical 
nursing care. 
2.3.4.1 NURSING CARE 
With all of the following antithrombotic agents, the nurse should check for signs of 
bleeding such as bleeding or oozing from a wound or venipuncture sites; nosebleeds; 
blood in urine, stools, sputum, or emesis; unexplained bruising; dizziness or confusion; a 
rapid or unusual heartrate; chest pain or shortness ofbreath; nausea or vomiting. The 
nurse should monitor the CBC, clotting times, renal and liver function tests and report 
any abnormalities to the doctor (Karch 2000: 68, 146, 330, 418-419, 1093, 1136, 1141). 
2.3.4.2 ASPIRIN 
Aspirin inhibits platelet production ofthromboxane A2, a platelet-specific 
prostaglandin. As mentioned in section 2.3.3, when platelets adhere to collagen after 
initial vessel damage, this triggers the conversion of arachidonic acid in the platelet 
plasma membrane to thromboxane A2, which powerfully stimulates platelet aggregation. 
Thus, aspirin inhibits platelet aggreatation, and its effects last approximately eight days. 
There is no tolerance build-up to aspirin in the body and spontaneous, life-threatening 
bleeding is rare. It is inexpensive, thus cost-effective (Verheugt 1999: 20-23). 
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It is important that the nurse knows that aspirin should not be given if the patient has 
allergies to salicylates or nonsteroidal anti-inflammatory drugs (NSAIDs), bleeding 
and/or coagulation disorders, bleeding ulcers, chickenpox, influenza, surgery within one 
week, impaired renal function or is pregnant or lactating (Karch 2000: 144-145). 
2.3.4.3 SECOND GENERATION PLATELET INHIBITORS 
Second-generation platelet inhibitors include the adenosine diphosphate (ADP) inhibitors 
clopidogrel (Piavix) and ticlopidine (Ticlid). The initial platelet adherence to collagen 
triggers the platelets to release the contents of their secretory vesicles, one of which is 
ADP. When platelets are activated by agents such as collagen, thrombin or ADP, they 
change shape, leading to platelet aggregation. Colpidogrel and ticlopidine block ADP 
receptors on platelets, thus preventing platelet aggregation. They are less potent than the 
GP lib/lila inhibitors, and are often used along with aspirin for one month post-stent 
placement. Unlike aspirin, these agents provide a broader inhibition of platelet 
aggregation but do not have any effect on thomboxane A2 or prostaglandin synthesis as 
does aspirin. 
Ticlopidine was originally u8ed, but there has been a significant incidence of bone 
marrow suppression associated with its use, and consequently it is usually recommended 
only if the patient has an intolerance to aspirin and to the continued use of clopidogrel. 
Ticlopidine also prolongs bleeding time. It is used for maintenance, not acute, therapy. 
Clopidogrel may be used with aspirin or as an alternative to aspirin to decrease platelet 
aggregation, and is indicated as part of maintenance, not acute, therapy. Unlike aspirin or 
ticlopidine, clopidogrel does not prolong bleeding time. 
It is important that the nurse not give these agents if the patient is allergic to them, has 
neutropenia, thrombocytopenia, hemostatic disorders, bleeding ulcer, intracranial 
bleeding, severe liver disease, or is lactating. Although not as common as with aspirin, 
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these drugs may cause GI upset, so the nurse should give them with food (Futterman & 
Lemberg 2000:73; Verheught 1999: 20-23). 
2.3.4.4 GLYCOPROTEIN lib/lila RECEPTOR INHIBITORS 
Third-generation platelet inhibitors are the glycoprotein lib/lila receptor inhibitors (GP 
lib/lila inhibitors) and currently include abciximab (ReoPro), eptifibatide (Integrelin) 
and tirofiban (Aggrastat). These agents are indicated for unstable angina and non-Q-
wave MI and to prevent thrombotic and ischemic complications in PCI. These drugs 
inhibit platelet aggregation by binding with the GP lib/lila receptor site on the platelet 
instead of fibrinogen and other ligands, thereby preventing or stopping platelet 
aggregation. GP lib/lila inhibitors are most effective because they completely block 
fibrinogen's ability to bind platelets. 
These agents can be given alone or in combination with heparin. Recent study results 
indicate that using GP llbillla inhibitors with heparin and reduced-dose thrombolytic 
therapy improves vessel patency in acute non-Q-wave MI. All three are given 
intraveneously, but oral GP lib/lila inhibitors are being researched (Gylys & Gold 2000: 
3-4; MacCallum, Hanlon & Byrne 1999: 34-35; Miracle & Woods 2000: 19). 
These agents increase bleeding time, but after discontinuation, the effects on the platelets 
disappear within hours. Used along with heparin and aspirin, or with low-molecular 
weight heparin and aspirin in ACS patients, they show a reduction ofMI and death up to 
25 times compared to heparin and aspirin alone. Their beneficial effects are seen in 
patients undergoing PCI and also in those without such procedures. They are expensive 
(up to $1 000 per treatment), which presently makes them prohibitive for routine use. 
Oral GP lib/lila inhibitor agents, under investigation currently, have a longer plasma life 
(Verheught 1999: 20-23). 
The nurse should not give GP lib/lila inhibitors if the patient is allergic to them, ifhe has 
neutropenia, thrombocytopenia, hemostatic disorders, bleeding ulcer, intracranial 
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bleeding, uncontrolled or severe hypertension, major trauma or surgery within six weeks, 
aortic aneurysm, aortic dissection, or is pregnant. The nurse should administer these 
agents cautiously if the patient is lactating. 
2.3.4.5 HEPARIN 
Heparin has been most widely used for ACS up until now. It combines with 
antithrombin Ill, a naturally occurring substance in the body, the function of which is to 
partially block the effects of thrombin. Heparin increases this effect at least a thousand 
fold, and that in turn greatly slows down the conversion of :fibrinogen to fibrin. Heparin's 
powerful effects on thrombin also greatly increase the risk ofbleeding. Its effects are 
measured by prolongation of the activated partial thromboplastin time (PTT). 
Therapeutic levels range from 50 to 90 seconds (Sieck 2000:7; Verheugt 1999: 20-23). 
For ACS, heparin can be administered intraveneously with a loading dose of 5000 units, 
followed by a continuous IV infusion of 1000 units/hour. Clotting times should be 
monitored and the heparin dose should be increased or decreased according to the 
doctor's orders to maintain a PTT 1.5 to 3 times the control value (usually between 50 to 
90 seconds). Heparin also may be given subcutaneously (SQ), usually every 8 hours. 
The nurse should not give heparin if the patient is allergic to it, has thrombocytopenia, 
uncontrolled bleeding, or cannot be monitored regularly with blood coagulation tests. 
Heparin should not be given during labor or during the immediate postpartum period, or 
to women older than 60 years who are at high risk for hemorrhaging. It should not be 
given to patients who have had recent trauma or surgery. Treatment for heparin overdose 
is 1% protamine sulfate, and the nurse should know that drug dosage of protamine sulfate 
is based on blood coagulation studies (Gurfinkel1999: 115-117; Karch 2000: 587-589; 
Sieck 2000: 7-9). 
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2.3.4.6 LOW MOLECULAR WEIGHT HEPARIN 
Low molecular weight heparin (LMWH) intereferes with the clotting cascade by 
blocking the conversion of factor X to its activated form. As a result, prothrombin 
activator cannot activate prothrombin to be converted to thrombin. Enoxaparin 
(Lovenox) is the LMWH currently being used for ACS. LMWH consists of a smaller 
molecule of the compounds of which heparin is a mixture. The pharmacological 
response ofLMWH is more predictable than heparin and does require monitoring the 
PTT. It can be administered subcutaneously, which makes it possible for outpatient use. 
Full anticoagulation can be achieved with one to two SQ injections daily. LMWH is 
associated with a lower incidence of thrombocytopenia, it has a longer half-life and 
causes fewer bleeding complications than standard heparin. Because of its ease in 
administration and lack of need for monitoring, it has become the preferred treatment for 
ACS. 
Recent studies have shown improvements in mortality for patients admitted with unstable 
angina or non-Q-wave MI who received LMWH (the ESSENCE trial). These patients 
also had reduced requirements for diagnostic coronary catheterizations and 
revascularizations. Follow-up studies on the ESSENCE trial are being performed to 
investigate the effect of prolonged use ofLMWH beyond the acute phase ofunstable 
angina (Scirica 1999: 115-116). 
The nurse should not give LMWH if the patient is allergic to it or allergic to heparin or 
pork products, or in the case of severe thrombocytopenia or uncontrolled bleeding. The 
nurse should give LMWH cautiously if the patient is pregnant, lactating or has a history 
ofGI bleed. It is given subcutaneously, usually every 12 hours, in the abdominal area at 
least two inches from the belly button. (Gurfinkel 1999: 115-117; Sieck 2000: 7-9; 
Roberts 1999: 7-9; Karch 2000: 66-67, 145-146, 330, 460-461, 588-589, 1136, 1140-
1141). 
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Figure 2.4 is a schematic illustration, redrawn by this author, which shows where heparin 
and low molecular weight heparin exert their antithrombotic effects on the coagulation 
cascade (Sieck 2000: 7). 
Figure 2.4 The "old" heparin versus the "new" 
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2.4 ENDOTHELIAL DAMAGE 
The endothelium is the layer of cells that forms a blood or lymphatic vessel's inmost 
lining, as well as that of the heart. The endothelium does more than serve as a semi-
permeable between the blood supply and the smooth muscle cells of the vascular wall. It 
performs many other vital functions as well - it regulates smooth muscle tone, cell 
proliferation and synthesis and release of vasoactive chemicals; its nonadhesive surface 
ensures unimpeded blood flow; and in healthy persons, it exhibits antithrombotic and 
fibrinolytic properties. 
By regulating the production of several vasoactive substances, the endothelium maintains 
equilibrium between vasodilation and vasoconstricition, coagualation and 
anticoagulation, and cellular growth and inhibition. Endothelial damage always causes 
a shift toward vasoconstriction, as well as toward blood coagulation and cellular growth 
(Rockett 1999: 44-46). 
2.4.1 FACTORS LEADING TO ENDOTHELIAL DAMAGE 
Endothelial damage can occur as a result of several factors. Chronic minimal damage 
can begin merely as a result of the disturbance of blood flow patterns at vessel bending 
points and near bifurcations of arterial trees. These local shear forces are enhanced by 
hypertension, resulting in high shear forces which can damage the endothelium. 
Microtears in the vessel wall can occur from distension and venous stasis as well as from 
direct insult from trauma (especially fractures), surgery (including PCI), sepsis and burns. 
General anesthesia can decrease vascular tone, disrupting the endothelial lining. 
Endothelial damage causes an imbalance in several vasoactive substances, which will be 
discussed in the next section, and also exposes collagen, the underlying connective tissue 
ofthe epithelium (Breen 2000: 60-61; Church 2000: 35-36). 
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2.4.2 FUNCTIONS AND DYSFUNCTIONS OF THE ENDOTHELIUM 
2.4.2.1 DILATION 
Several substances released from the endothelium mediate blood vessel dilation, two of 
which are nitric oxide and prostaglandin. When blood pressure is normal, the 
endothelium releases small amounts of nitric oxide continuously, overcoming the vessel's 
natural tendency to constrict, and dilating the vessel enough to maintain homeostasis. 
When the endothelium is damaged, sufficient amounts of nitric oxide may not be released 
and the blood vessels do not relax adequately, which can cause elevated blood pressure. 
2.4.2.2 CONSTRICTION 
The endothelium also produces chemicals that cause vasoconstriction. One of these 
chemicals, angiotension-converting enzyme (ACE) converts peptide angiotension I to 
angiotension II, a potent vasoconstrictor. Angiotension II blocks the release of nitric 
oxide and prostaglandin. Thus, ACE has a dual effect: converts angiotension I to 
angiotension II, a powerfulvasoconstrictor; and interferes with two vasodilators (nitric 
oxide and prostaglandin). 
Some ACE circulates in the blood continuously, but most of it is in the endothelial 
tissues. If you could physically take out ACE, angiotension II levels would drop, while 
nitric oxide and prostaglandin levels would rise, favoring dilation and resulting in a 
decreased blood pressure (Rockett 1999: 44-49; Weissberg 2000: 247). 
2.4.2.3 MONOCYTE AND PLATELET ADHESION 
Monocytes, from which macrophages come, cause plaque to be deposited on the 
endothelium. This will be discussed in the following section on plaque formation. The 
endothelium helps to regulate the number of inflammatory cells, such as monocytes and 
macrophages, that bind to the blood vessel wall. When the endothelium is damaged, 
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more inflammatory cells bind to the vessel wall, thus leading to an increase in plaque 
formation. 
Nitric oxide and prostaglandin also inhibit platelet aggregation and adhesion, and a 
decrease in these chemicals due to endothelial damage results in platelet aggregation and 
adhesion, which can lead to thrombus formation. Concurrently, when nitric oxide levels 
fall, there is a corresponding increase in the oxidation of circulating low-density 
lipoprotein (LDL) cholesterol. When LDL cholesterol is oxidized, it punctures the 
endothelial cell walls, causing further damage. Where such damage occurs, platelet 
aggreation and adhesion also occur (Rockett 1999: 44-49; Karch 2000: 14-15). 
2.4.2.4 CELL GROWTH AND INHIBITION 
The endothelium regulates several chemical mediators that affect the cellular growth of 
vascular smooth muscle (VSM). Nitric oxide and prostaglandin inhibit VSM growth, 
and angiotension II stimulates VSM growth. An imbalance can alter the thickness of 
both the blood vessel wall and its lumen. This vascular remodeling can result in a 
thickened vessel wall and a narrower-than-usual lumen, leading to hypertension. This 
type of vascular remodeling can predispose people to other problems such as 
atherosclerosis, MI, stroke and renal failure (Rockett 1999: 44-49; Fuster et al 1999: 5-9; 
Weissberg 2000: 247-249). 
2.4.2.5 ACE INHIBITOR DRUGS 
ACE inhibitor agents are a class or drugs that inhibit tissue-ACE release and allow nitric 
oxide and prostaglandin levels to rise. For ACS patients, these drugs help to lower blood 
pressure, inhibit vascular smooth muscle growth, inhibit platelet aggregation and 
adhesion, and possible slow oxidation ofLDL cholesterol. ACE inhibitor agents will be 
discussed in section 2.9 covering drugs used for treating ACS. 
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2.4.2.6 SUMMARY OF ENDOTHELIAL DAMAGE 
Endothelial damage results in the following phenomena: impairment ofvasoregulation, 
monocyte adhesion, platelet adhesion and vascular smooth muscle growth. These may 
result in vasoconstriction, hypertension, plaque formation and thrombus formation 
(Rockett 1999: 44-49; Fuster, Fayad & Badimon 1999: 5-9; Breen 2000: 58-62). 
2.5 PLAQUE FORMATION 
2.5.1 INTRODUCTION 
Atherosclerosis begins as a subendothelial accumulation of lipid rich, monocyte-derived 
foam cells and associated T -cells which form a non-stenotic fatty streak. As this 
progresses, the lesions take the form of a core of cholesterol esters surrounded by an 
endothelialized fibrous cap containing vascular smooth muscle cells (VSMC) and 
inflammatory cells (mostly macrophages with some T-cells and mast cells). In advanced 
lesions, there may be new blood vessels and deposits of calcium. 
2.5.2 HOW ATHEROSCLEROTIC PLAQUE BEGINS 
The earliest detectable physiological manifestation of atherosclerosis is a decreased 
production of nitric oxide. This is even seen in children with hypercholesterolemia, and 
is consistent with the hypothesis that increased levels of circulating atherogenic 
lipoproteins may lead to endothelial dysfunction and subendothelial lipid accumulation. 
It should be noted, however, that it has not been yet proven which comes first - the 
endothelial damage or the increased circulating lipoproteins. 
As a brief review, endothelial damage leads to a decrease in the production of nitric oxide 
and prostaglandin, causing vasoconstriction, platelet aggregation, vascular smooth 
muscle proliferation and monocyte adhesion. These changes brought on by endothelial 
damage are closely linked with plaque formation, as we shall see. 
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When levels of circulating lipoproteins in the blood increase, inflammatory monocytes 
are activated and migrate from the arterial lumen to the subendothelial space. It is 
important to note that these inflammatory cells will not accumulate in the intima in the 
absence of lipids. Monocytes mature into macrophages, which have the ability to injest 
modified lipids and become macrophage foam cells. Foam cells can also be 
appropriately termed as "intracytoplasmic droplets of cholesterol", because the 
macrophages injest the lipids. 
As the number of foam cells increases along with associated T -cells, a fatty streak is 
formed on the arterial lumen wall. The fatty streak is an early atherosclerotic lesion 
(designated Type II by the American Heart Association) and is not associated with 
evidence of any structural damage to the endothelium. 
As the fatty streak lesion increases in size, it forms a lipid-rich core (designated as Type 
IV and Va by the American Heart Association) containing cholesterol esters. The 
vascular smooth muscles respond by forming a fibrous connective tissue cap over this 
lipid core of atherosclerotic plaque. This cap separates the highly thrombogenic lipid-
rich core from the arterial lumen and from circulating platelets and proteins of the 
coagulation cascade. It also gives structural stability to the lesion. This cap also contains 
some inflammatory cells, most of which are mainly macrophages with some T-cells and 
mast cells. These macrophages are very active, producing procoagulant tissue factor and 
many other inflammatory cell mediators, such as tumor necrosis factor, interleukins and 
metelloproteinases. Some of these macrophages contain cholesterol (foam cells). 
Vascular smooth muscle cells are the only cell capable of making this cap, and thus they 
play an important part in maintaining plaque stability and protecting against plaque 
rupture and consequent thrombosis (Davies 2000: 361-366; Fuster et all999: 5-9; 
Weissberg 2000: 247-252). 
32 
2.5.3 HOW ATHEROSCLEROSIS LEADS TO ACS SYMPTONS 
The first way atherosclerosis leads to symptoms is if the lesion becomes large enough to 
restrict blood flow to the point that the oxygen supply cannot meet the demand. This 
results in tissue ischemia, such as in chronic stable angina. 
It must be emphasized that plaque growth does not always lead to lumen stenosis. The 
arteries can remodel and accommodate the expanding atherosclerotic lesion and still 
maintain a normal or adequate lumen diameter. Thus, atherosclerotic lesions may or may 
not be clinically silent. 
The second way atherosclerosis leads to symptoms is if the lesion ruptures or erodes (this 
will be discussed in Section 2.6). This triggers platelets to rapidly accumulate and 
intravascular thrombosis will occur, leading to acute coronary syndromes of unstable 
angina and myocardial infarction (Simoons, Boersma & Vandeerzwaan & Deckers 
1999: 1-4). 
2.5.4 SUMMARY OF PLAQUE FORMATION 
To summarize, increased levels of circulating lipoproteins in the blood correlate with 
endothelial damage and dysfunction. It is not proven yet which happens first. The 
increased lipid accumulation is followed by inflammatory cells, particularly monocytes, 
being activated and migrating to the subendothelial space. As activated monocytes 
adhere to the area, they mature to macrophages which ingest modified lipids and become 
foam cells. These foam cells initially form a fatty streak, and as the fatty streak lesion 
increases in size, it forms a lipid-rich core surrounded by a fibrous connective tissue cap. 
This cap separates the core from the arterial lumen and circulating platelets and proteins, 
and also gives structure and stability to the core (Fuster et al 1999: 5-9; Davies 2000: 
361-364; Weissberg 2000: 247-251). 
33 
2.6 PLAQUE RUPTURE 
2.6.1 INTRODUCTION 
Plaques with a lipid-rich core and an unstable cap are more likely to rupture. A thicker 
cap is more able to resist mechanical stresses in the body. However, the most important 
determinant of plaque stability is the composition, not necessarily thickness, of the 
fibrous cap. A larger number of inflammatory cells and a relative smaller number of 
vascular smooth muscle cells will more easily lead to plaque rupture. The inflammatory 
cells weaken and destroy the fibrous cap, and vascular smooth muscle cells are not 
equipped to compensate. The reverse is also true - a smaller number of in:tlammatory 
cells and a relative larger number of vascular smooth muscle cells will lead to increased 
cap stability and less likelihood of plaque rupture. 
Therefore, it is not so much the size of the plaque as it is plaque composition that 
determines the outcome. A person can have a small, hemodynamically insignificant 
atherosclerotic plaque that is clinically silent, and without any warning it can rupture. 
When the fibrous cap of an atherosclerotic lesion ruptures, it exposes the highly 
thrombogenic collagenous matrix and lipid core to the circulating blood and leads to 
platelet accumulation and aggregation. The clotting cascade is activated, and this leads to 
fibrin deposition, thrombus formation, and, at the most extreme, vessel occlusion. Small 
lesions can progress acutely to severe stenosis or total occlusion, and this progression is 
unpredictable and episodic. 
However, vessel occlusion is not inevitable, and it is now clear that episodes of silent, 
subclinical plaque rupture occur frequently in patients with atherosclerosis. These 
episodes of non-occlusive plaque rupture trigger the recruitment of new vascular smooth 
muscle cells to the area, and form a new fibrous cap over the thrombus, thereby 
increasing the size ofthe lesion. Thus the size of the atherosclerotic lesions increases as 
a consequence of repeated episodes of rupture and repair (Davies 2000: 361-366; Fuster 
et al1999: 55-59; Weissberg 2000: 247-252). 
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2.6.2 HOW PLAQUE RUPTURE OCCURS 
Plaque disruption depends on both passive and active phenomena. Passive plaque 
disruption usually occurs where the fibrous cap is the thinnest and most heavily 
infiltrated by foam cells, and therefore the weakest. Vulnerability to rupture depends on 
the location, size and consistency of the lipid core; and on blood-flow characteristics, 
especially the impact of the flow on the proximal part of the plaque. 
Active plaque disruption involves the action ofmacrophages, which are capable of 
degrading the fibrous cap by phagocytosis or secretion of proteolytic enzymes. These 
enzymes may weaken the fibrous cap and predispose it to rupture (Davies 2000: 361-366; 
Fuster et al1999: 55-59; Weissberg 2000: 247-252). 
Plaques at risk for future thrombotic events are characterized by: 
0 large lipid cores (greater than 50% overall plaque volume) 
0 thin caps 
0 high density of macro phages, capable of degrading the fibrous cap 
0 low density of smooth muscle cells in fibrous cap 
2.7 VASCULAR REMODELING 
Plaque rupture and thrombus formation does not always lead to vessel occlusion. 
Research has shown that it is clear that episodes of silent, subclinical plaque rupture 
occur frequently in patients with atherosclerosis. These episodes of non-occlusive plaque 
rupture trigger new vascular smooth muscle cells to migrate to the area and form a new 
fibrous cap over the thrombus, thereby increasing the size of the lesion. Thus the size of 
atherosclerotic lesions increases as a consequence of repeated episodes of rupture and 
repair (Fuster et all999: 5-9; Weissberg 2000: 247-252). 
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2.8 STATIN DRUGS 
Statins are a class of drugs that reduce the rate of progression of pre-existing lesions and 
the incidence of new lesion formations by lowering serum cholesterol and serum LDLs, 
and by stabilizing plaque. Section 2.5 discussed how lesions grow by repeated episodes 
of subclinical rupture and repair, and how silent occlusions can happen when plaque 
ruptures and thrombosis occurs in the case of a well collateralised myocardial circulation 
such that no significant ischemia results from the occlusion. The use of statins appears to 
stabilize plaque, which means repeated plaque rupturing can be prevented, thus halting or 
slowing growth of existing lesions. By lowering serum cholesterol and serum LDLs, 
fatty streak and plaque formation can be slowed down or prevented. Statins have only a 
small effect on reducing the size of pre-existing lesions. (Weissberg 2000: 251). 
2.9 DIAGNOSIS OF PLAQUE PRESENCE 
Angiography can only detect lesions that impinge significantly on the arterial lumen, and 
does not give any information on the compostion of the lesion. Since composition, rather 
than size, determines the likelihood of plaque rup~ure, angiography is a poor predictor of 
clinical events. In addtion, as mentioned before, a small lesion undetected by 
angiography, if unstable, can spontaneously rupture and lead to ACS. The following four 
diagnostic methods are currently being used and researched to detect the presence and 
composition of atherosclerotic plaque (Klootwijk & Hamm 1999: S10-S14; Weissberg 
2000: 249-251 ). 
D Electron beam computerized tomography (CT) 
D Magnetic resonance imaging (MRI) 
D Positron emission tomography (PET) 
D Biochemical markers of plaque inflammation 
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2.10 ECG CHANGES INDICATIVE OF ACS 
In order to understand what the ECG changes represent, a review of a few key terms will 
be presented with ECG changes relative to each term. 
2.10.1 UNSTABLE ANGINA 
Angina pectoris (chest pain), the classic symptom of coronary artery disease (CAD), 
occurs when the heart does not receive a sufficient supply ofblood and oxygen 
(ischemia is another term for deficient blood supply to a body part). Angina is 
considered unstable angina if symptoms occur unpredictably or if previously stable 
conditions become more intense, last longer, or radiate to a different location than usual. 
Unstable angina is not always caused by exertion- it can occur during rest or sleep, and 
it is not always relieved by rest and NTG. It indicates severe coronary vessel narrowing 
from atherosclerotic plaque, a small thrombus, or arterial spasms. Myocardial ischemia 
is indicated on ECG by ST depression of 1 mm or more above the isoelectric line in 2 or 
more continguous leads, or T -wave inversion. It is usually a reversible, transient event 
that is corrected when the blood and oxygen supply to the myocardium is restored 
(Dennison 1996: 107-108; Sieck 2000: 5-6). 
2.10.2 MYOCARDIAL INFARCTION (MI) 
Myocardial infarction is the term used to describe irreversible cellular loss and 
myocardial necrosis that result from prolonged ischemia to a specific area of the 
myocardium. It is the destruction of a sufficient amount ofheart tissue to cause clinical, 
electrical and/or biochemical changes in the body, and is indicated on ECG by ST-
segment elevation of 1 mm or more in 2 or more contiguous leads (Dennison 1996: 11 0; 
Thelan et al 1994: 283-284). 
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2.10.2.1 Q-WAVEMI 
A Q-wave MI, also called a transmural infarction, affects all three layers of the heart 
wall, the epicardium, myocardium, and endocardium. It is associated with higher 
frequency of complete coronary occlusion and infrequent coronary collaterals. It is 
indicated on ECG by ST -segment elevation of 1 mm or more in 2 or more contiguous 
leads, and by a Q-wave greater than 0.04 seconds in width and 25% the height of the R-
wave. If all 3 layers of the myocardium have been affected, a Q wave appears within a 
few hours to a few days after the occlusion. The Q-wave may decrease over time 
following a Ml, but it will always be present in a 12-lead ECG (Gylys & Gold 2000: 3-
13; McAvoy 2000: 34-39; Statland 1996: 43-51; Church 2000: 34-42; DeWood 1988: 
36F-38F). 
2.10.2.2 NON-Q-WAVE MI 
Some people experience aMI without developing Q-waves. A non-Q-wave MI does not 
affect all three layers of the heart. It is associated with a lower frequency of complete 
coronary occlusion and is more common with diabetics or those who have developed 
good coronary collateral circulation. It is indicated on ECG by ST -segment depression 
which could flip up as the blockage develops into a full-thickness injury. Although non-
Q-wave MI was originally considered to be less serious than Q-wave MI, subsequent 
studies have shown that the incidence of death and recurrent MI is as great as that 
associated with Q-wave infarctions (Gylys & Gold 2000: 3-13; McAvoy 2000: 34-39; 
Statland 1996: 43-51; Church 2000: 34-42; DeWood 1988: 36F-38F). 
2.10.3 LIMITATIONS OF ECG AS A MARKER OF ACS 
Patients with acute MI can frequently present with nondiagnostic ECG's, whether as a 
result of conduction system delays (e.g. left bundle branch block), nonspecific ST-and T-
wave changes, or Ml's involving the posterior wall. Improvements in capturing ECG 
information -- such as 15-lead systems, continuous vectocardiograms, or ST -segment 
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monitoring- can improve sensitivity of detection of ACS, but still cannot give a 
definitive diagnosis on all patients. 
2.11 CARDIAC ENZYMES (MARKERS) 
Following is a discussion of three cardiac enzymes (markers) used to detect a myocardial 
infarction or rule it out with their normal values and advantages and disadvantages of 
each. 
2.11.1 MYOGLOBIN I Normal: 10-13 units/L 
Myoglobin is a low molecular weight protein found in all muscle that is rapidly released 
into the bloodstream when there is muscle damage. An increase in serum myoglobin is 
seen earlier than any other cardiac marker, and appears in serum 1 to 3 hours after the 
onset of chest discomfort; levels peak in 6 to 9 hours and return to normal in 20 to 24 
hours. The presence of myoglobin, coupled with clinical signs and symptoms, suggest 
myocardial injury.· Another advantage is that laboratories can perform rapid testing, 
which means test results are obtained quickly. 
Because myoglobin exists in other tissues than just the myocardium, any injury to 
skeletal muscle can cause a rise in myoglobin levels, including skeletal or neuromuscular 
disorders, trauma, injections with needles, strenuous exercise, surgery, renal failure, 
multisystem organ failure, alcohol abuse, hypothermia and hyperthermia. In other words, 
the test is not very sensitive. Increased levels of serum myoglobin alone cannot be used 
to rule in aMI, but can be used as an initial screening tool (Ryan 2000: 26-30; Statland 
1996: 43-51). 
2.11.2 CREATINE PHOSPHOKINASE (CPK) I Normal: 10- 13 units/L 
Creatine phosphokinase (CPK) is an enzyme that exists in cardiac and skeletal muscle, 
as well as in the brain, and can be :fractioned into three closely related enzymes, or 
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isoenzymes. CPK-MB (MB means "myocardial band") is the cardiac component. Once 
thought to be the "gold standard" for detecting myocardial damage, recent research has 
shown that CPK-MB readings can be influenced by a number of factors such as trauma, 
multi-organ damage, high doses of salicylates, strenuous exercise, surgery, myocarditis 
and rhabdomyolysis. 
CPK-MB usually starts to rise 3 to 6 hours after the onset of myocardial damage, peaking 
in 12 - 24 hours, and returning to normal in 48 - 72 hours. The test is often used to 
screen for myocardial damage but cannot definitively prove its presence. It is also used 
to monitor the progress of an MI and the effectiveness oftreatment. 
Up until recently, CPK-MB analysis was time-consuming, labor-intensive and expensive, 
making it difficult to obtain rapid results. However, newer analysis systems take faster 
measurements and improve the turnaround time, but it is still not optimal (Ryan 2000: 
26-30; Statland 1996: 43-51). 
2.11.3 TROPONINS T AND I 
Troponins, which are proteins found in cardiac and skeletal muscle, exist in three 
different forms: troponin T, troponin I, and troponin C. Troponin Cis identical in both 
muscle types and is useless as a cardiac marker. The structures oftroponin T and 
troponin I in the cardiac muscle are different from the troponins in skeletal muscle, so 
they are easily differentiated in lab analysis. Numerous studies have shown the troponins 
to be as acurate and reliable as CK-MB, and actually better, because of their greater 
cardiac specificity than CK-MB. In addition, troponin normally is not present in serum 
until cardiac cell necrosis occurs, so even negligible levels are important and allow for 
improved diagnosis of cardiac injury, especially in a situation where severe skeletal 
muscle damage has occurred. 
Both troponins remain elevated for longer periods of time (5-9 days for troponin I, and up 
to 14 days for troponin T). Thus, sensitivity remains high a long time after CK-MB 
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levels have returned to normal. This long-term delay is advantageous when dealing with 
patients who delay seeking medical care for a MI because of misleading symptoms. 
Another advantage of the troponins is that their serum concentration in acute MI is 
independent of muscle mass. 
2.11.3.1 TROPONIN T I normal: less than 0.1 nglml 
Cardiac troponin Tis released 3 to 4 hours after myocardial damage occurs, and you 
may also get elevated readings with unstable angina and uremia. This limitation makes 
the test helping in ruling out a MI, but less helpful in diagnosing one. This test is also 
costly and takes at least 45 minutes to get results. 
2.11.3.2 TROPONIN I I normal: less than 0.6 nglml 
Cardiac troponin I is released 4 to 6 hours after myocardial damage, which is helpful 
again in ruling out an MI. Because levels do not increase in the presence of unstable 
angina or renal failure, this test is also very helpful in confirming a MI. The test is 
expensive, but can be done in only 15 -'-- 20 minutes. 
Some manufacturers suggest the normal value is anything less than 1.6. The general 
consensus is that if the troponin I value is between 0.6- 2.0, the patient probably had a 
MI, but it should be confirmed with CK-MB and ECG. Without an increase in CK-MB 
and significant ECG changes, it might possible be acute ischemia. If the value is greater 
than 2.0, it most probably is aMI (Adams 1999: 127-134; Ryan 2000: 4-8; Statland 1996: 
43-51; Ross, Bever, Uddin & Hockman 2000: 29-31 ). 
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2.12 ADDITIONAL DRUGS USED TO TREAT ACS AND RELATED 
SYMTOMS 
In Sections 2.3, 2.4 and 2.6 some of the drugs used to treat ACS were discussed. In this 
section, six other classes of drugs will be covered that are used to treat ACS. 
The initial approach to patients with ACS is urgent admission to emergency care with 
hemodynamic and ECG monitoring, usually done in an ambulance or emergency room of 
a hospital. After monitoring and venous access is started, rapid general and causal 
treatment is started. 
General treatment for ACS consists of pain relief and limitation of myocardial ischemia. 
More causal treatment involves antithrombotic therapy. Pain relief can be achieved by 
NTG and/or morphine sulfate. Anti-ischemic therapy is aimed at decreasing the ischemia 
in order to prevent myocardial necrosis. Antithrombotic therapy is given to inhibit clot 
formation and propagation. In cases of suspected total coronary artery occlusion, clot 
lysis or clot destruction is the main goal. 
After these treatments, most patients become free of symptoms. When signs and 
symptoms of myocardial ischemia recur, patients usually undergo cardiac catheterization 
and subsequent revascularization, when feasible (Verheugt 1999: 20-23). 
2.12.1 MORPHINE SULFATE 
Pain relief can be achieved by the use of nitroglycerine, but is mostly guaranteed with 
morphine sulfate (MS), a narcotic agonist analgesic. For pain control, 2 - 4 mg. 
morphine intravenously may be given every 5 to 1 0 minutes, or more if needed if ordered 
by the physician. Besides controlling pain, morphine relieves anxiety and promotes 
vasodilation. The nurse should use it with caution, as respiratory depression may occur 
in the or the very ill. Patients already receiving barbiturate general anesthetics are more 
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prone towards respiratory depression, hypotension, profound sedation or coma if given 
morphine (McAvoy 2000: 38; Karch 2000: 815-816). 
2.12.2 NITROGLYCERINE 
Nitroglycerine (NTG), a nitrate, is the most common drug in the acute treatment of 
myocardial ischemia. Nitroglycerine relaxes vascular smooth muscle with a resultant 
decrease in venous return and a decrease in arterial blood pressure. It thus reduces left 
ventricular workload and decreases myocardial oxygen consumption. Sublingual NTG 
or NTG mouth spray are used in acute treatment of ischemia in ambulatory patients and 
can also be used as a prophylaxis. In ACS, intravenous NTG is given both as acute 
treatment and as a maintenance infusion. NTG dosage is usually titrated either on 
symptoms or on hemodynamic parameters such as heartrate and blood pressure. NTG 
may also be administered orally (sustained release), topically, transdermally and 
transmucosally, between lip and gum above incisors (Karch 2000: 859-860; Verheugt 
1999: 11-20). 
One major drawback with NTG is the rapid development of tolerance. Other side effects 
include hypotension and headache. The nurse should carefully monitor the patient 
hemodynamically when administering NTG. 
2.12.3 BET A-BLOCKERS 
Beta-adrenergic antagonists, or beta-blockers, block the beta-adrenergic receptors in the 
heart, decreasing the influence of the sympathetic nervous system and thereby reducing 
the excitability of the heart, cardiac workload, oxygen consumption and blood pressure. 
Beta-blockers also act as antidysrhythmics. By reducing heartrate and myocardial 
contraction, beta-blockers allow more time for perfusion of the myocardium. They are 
indicated to treat stable or unstable angina, hypertension and Ml. 
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·The benefits of early beta-blocker use after a MI are the antidysrhythrnic effect; ability to 
decrease mortality in the early stage ofMI and the ability to decrease the incidence ofMI 
extension and reinfarction. 
Major side effects of beta-blockers in acute MI are rare. Beta-blockers should not be 
used if any of the following conditions are present: hypotension, bradycardia, A V block 
or congestive heart failure. These agents should be used with caution in patients with 
bronchospasmic lung disease (e.g. asthma). For such, cardioselective beta-blockers (e.g. 
metoprolol or esmolol) may be given; noncardioselective beta-blockers (e.g. propanolol) 
should not be used (Dennison 1996: 115; Moser, Frazier, Worster & Clark 1999: 11-15; 
Verheugt 1999: 11-20). 
2.12.4 CALCIUM CHANNEL BLOCKERS 
Calcium channel-blockers are antianginal and antihypertensive. They inhibit the 
movement of calcium ions across the membranes of cardiac and arterial muscle cells, 
which results in the slowing of the velocity of conduction of the cardiac impulse, 
depression of myocardial contractility, and dilation of coronary arterioles. These effects 
lead to decreased cardiac work, decreased cardiac energy consumption, and increased 
delivery of oxygen to the myocardial cells. These drugs are appropriate for patients 
experiencing hypertension and cardiac ischemia. 
Side effects include hypotension, bradycardia, and fatigue. The nurse should monitor the 
patient hemodynamically while the drug is being titrated to therapeutic dose (MeA voy 
2000: 36; Verheugt 1999: S1121; Karch 2000: 31-32). 
2.12.5 ACE INHIBITORS 
Section 2.4 briefly discussed some ofthe effects ofangiotension-converting enzyme 
inhibitor agents (ACE inhibitors)- vasodilation with resulting decreased blood 
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pressure, decreased platelet aggregation and adhesion, decreased LDL oxidation, and 
decreased vascular remodeling. ACE inhibitors are recommended for a minimum of 6 
weeks (preferably longer) after aMI, as they decrease ventricular remodeling that occurs 
after aMI, preserving ventricular function. Recent research shows that these drugs also 
decrease the risk of recurrent MI (Topoll998: 571-572). 
Studies have shown that up to 14% of patients who experienced an acute MI later 
develop left ventricular dysfunction as a result ofloss of myocardial cells and subsequent 
ventricular remodeling. Over time, ventricular remodeling results in a loss of use of the 
infarcted tissue and a thinning of the infarcted zone. The remaining noninfarcted tissue 
then becomes more dilated in an attempt to maintain adequate flow, and this leads to 
chronic heart failure and death. Patients with both symptomatic and asymptomatic 
ventricular dysfunction are at risk for developing symptomatic heart failure, as well as 
other cardiac dysrhythmias, fatigue, decreased exercise tolerance, and overall decreased 
quality of life. For these reasons, the prevention ofleft ventricular dysfunction is a 
priority in the treatment of acute MI survivors. Because early intervention is the key to 
preserving left ventricular wall function, ACE inhibitors should be started within 72 
hours after a MI. After 4 to 6 weeks of therapy with ACE inhibitors, patients who do not 
show evidence of left ventricular dysfunction can stop treatment (Moser et all999: 13; 
McAvoy 2000:37; Fuster et al1999: 58-62). 
Side effects of ACE inhibitor agents include hypotension (especially in salt/volume 
depleted patients), tachycardia, congestive heart failure, fatal pancytopenia and gastric 
irritation. The nurse should closely monitor the patient's fluid status, blood pressure and 
heartrate and renal function. The nurse should give these drugs should be given shortly 
before or after meals to prevent gastric irritation. 
2.12.6 THROMBOLYTICS 
Reperfusion therapy with fibrinolytic agents, or tbrombolytics, is standard care for 
patients presenting to the hospital within 6 hours of MI symptoms and who have 
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significant ST-segment elevation on ECG (some hospitals give thrombolytics if the 
patient presents within 12 hours of onset of MI symptoms). 
These drugs work by converting inactive plasminogen to active plasmin, an enzyme that 
is responsible for breaking down fibrin clots. The primary goal of these drugs is to 
decrease mortality by rapidly restoring blood flow to the occluded infarct-related 
coronary artery(s). 
Streptokinase and urokinase are the first generation of fibrinolytic agents currently in use. 
Newer agents are more clot selective than streptokinase. They are alteplase (tPA, 
Activase); retaplase (rPA, Retavase) and anistreplase (APSAC, Eminase). 
Data from several large-scale studies have shown that the choice ofthrombolytic agents 
is less important to survival than is the delay between onset of symptoms and initiation of 
treatment. Patients in the RAPID II study who received treatment within 6 hours after the 
onset of symptoms had.better overall patency than did the patients receiving treatment 
between 6-12 hours (Kloner & Birnbaum 1997: 42-43). 
Absolute contraindications to thrombolytic therapy are: active internal bleeding; history 
ofCVA; recent (within 2 months) intracranial or intraspinal surgery or trauma; known 
bleeding disorders; severe uncontrolled hyptertension; prolonged or traumatic CPR; 
pregnancy; streptokinase contraindicated if the patient has received streptokinase within 
the last 6 months (rPA can still be given). 
Relative contraindications are major surgery or trauma within 10 days; cerebrovascular 
disease; recent GI or GU bleeding; high likelihood ofthrombus on the left side ofthe 
heart (e.g. mitral stenosis with atrial fibrillation); subacute bacterial endocarditis; 
significant liver dysfunction; patients receiving oral anticoagulants; diabetic hemorrhagic 
retinopathy; advanced age (over 70 years); any condition in which bleeding constitutes a 
significant hazard or would be particularly difficult to manage because of its location. The 
nurse should monitor closely for any adverse side effects of thrombolytic therapy such as 
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hemorrage, reocclusion, allergic reactions or reperfusion dysrhythmias, in addition to 
nursing care given when administering antithrombotic agents. Reperfusion dysrhythmias 
are usually transient and treatment is usually required only for sustained ventricular 
tachycardia, ventricular fibrillation and symptomatic bradycardia or block. Check for 
allergic reactions (to streptokinase) such as urticaria, fever, bronchospasms, dyspnea and 
dysrhythmias (Dennison 1996: 114-115; Roberts 1999: 7-9; Verheugt 1999: 81121). 
2.13 PERCUTANEOUS CORONARY INTERVENTION 
If ST -segment elevation persists despite medical treatments, or if chest discomfort 
continues despite a definitive diagnosis, the physician may choose invasive treatments 
such as percutaneous coronary intervention (PCI), a technique where the blocked 
vessels are mechanically opened up by angioplasty, atherectomy, or stent placement. 
Coronary artery bypass graft (CABG) surgery may be needed if the coronary vessels are 
totally occluded or untreatable by other methods. It is not within the scope of this 
research paper to discuss CABG surgery; however, PCI will be briefly discussed in order 
to understand the range of treatment options tor ACS. 
2.13.1 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY 
Percutaneous transluminal coronary angioplasty (PTCA) involves the insertion of a 
catheter through the radial or femoral artery, advancing it to the coronary arteries, and 
inflating the balloon-tipped end of the catheter intermittently in the area of coronary 
artery stenosis caused by plaque. This dilates the stenotic area and improves blood flow 
through it. PTCA is an alternative to both traditional medical management of coronary 
artery disease and CABG surgery, and is a valuable adjunt to thrombolytic therapy in 
some cases (Thelan et al 1994: 330; Dennison 1996: 1 09). 
2.13.2 CORONARY ATHERECTOMY 
Coronary atherectomy is the removal of plaque from a coronary artery by cutting, 
shaving or grinding off the plaque. 
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Research and practical experience have shown that PTCA with a balloon catheter is not 
the best therapy in patients with complex, tortuous coronary lesions. Complication rates 
for balloon angioplasty are higher for longer (1 0 20 mm long), highly calcified type 
lesions. Complications include inability to cross a lesion with a typical PTCA wire and 
balloon, aprupt closure of the vessel, major arterial dissection and restenosis. 
Consequently, other approaches and treatment have been sought. 
In traditional PTCA, inflation of the balloon catheter causes distention of the vessel wall. 
Rotational atherectomy, the most commonly used type of atherectomy, causes minimal 
swelling of the arterial wall and allows treatment of lesions that are not easily approached 
with traditional angioplasty alone (Thorbs, Barbiere, Wayland & Morgan 2000: 77-80). 
2.13.3 CORONARY ARTERY STENTS 
Coronary artery stent placement involves the use of a stainless steel wire coil that acts 
as a scaffolding device to support a coronary artery and maintain patency after PTCA. 
The stent is introduced over a guidewire in a region previously dilated by PTCA to 
prevent acute closure and restenosis, as well as to obtain a larger vascular lumen 
diameter. 
2.13.4 COMPLICATIONS OF PTCA, ATHERECTOMY AND STENT 
PLACEMENT 
The following complications can occur as a result of any one ofthese PCis: coronary 
artery dissection, caused by catheter trauma; cardiac tamponade, caused by cardiac 
perforation; dysrhythmias; acute reocclusion or closure caused by trauma to the intima 
initiating the clotting cascade or coronary artery spasm; chronic restenosis caused by 
intimal hyperplasia; hypotension or bradycardia (vagal reaction) caused by increased 
parasympathetic nervous system stimulation during sheath removal; and subacute stent 
thrombosis. 
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Although stents have decreased restenosis rates and the need for target vessel 
revascularization, their use activates the GP-IIblllla receptors on platelet surfaces and 
predisposes to thrombus formation. This is reflected by the clinical syndrome known as 
subacute thrombosis, an event differing from abrupt closure or restenosis. Abrupt 
closure usually occurs within 24 hours following PTCA, whereas subacute stent 
thrombosis occurs in 1% to 3% of patients and develops 2 to 14 days after stent 
placement (Futterman & Lemberg 2000: 70-76; Thorbs et al2000: 77-84). 
2.13.5 NURSING MANAGEMENT FOR PCI PATIENTS 
The nurse should check the catheter puncture site frequently for bleeding or hematoma 
formation. Neurovascular checks should be performed frequently to assess for peripheral 
ischemia related to femoral or radial artery thrombosis. The nurse should monitor for 
signs and symptoms of retroperitoneal hemorrhage by checking for back or flank pain, 
postural tachycardia and/or hypotension. The affected limb should be kept flat and 
immobile and the head ofbed should not be elevated anymore than 30 degrees (if femoral 
site used) for the first 8 hours after PTCA. The patient should be on continuous cardiac 
monitoring, and the nurse should check for ECG changes (in particular ST- or T -wave 
changes) and onset of chest pain, indicated myocardial ischemia (Dennison 1996: 109-
11 0; Futterman & Lemberg 2000: 70-76; Thorbs et al 2000: 77 -841). 
2.13.6 FA CILIATED PCI 
Until recently, fibrinolytic drugs have been the treatment of choice for achieving rapid 
revascularization, with coronary angioplasy reserved as an option if the former did not 
achieve vessel patency. Traditionally routine PCI of the stenotic infarct-related artery 
following fibrinolytic therapy has not been recommended, because some evidence 
suggested that the procedure was not useful or effective and was perhaps even harmful. 
However, recent studies show that PCI is facilitated by a combination of therapies that 
enhance reperfusion. Preclinical and clinical investigations of fibrinolytic therapy plus 
GP-IIblllla inhibitors have shown that the dose of fibrinolytic therapy can be reduced by 
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approximately 25% to 50% when administered with GP-Ilblllla inhibitors. Fibrinolysis 
occurs more rapidly and completely and is more stable with combination therapy, as 
reflected by improved artery patency, which results in lower mortality and reinfarction 
rate and higher PCI success. This concept of administering this type of pharmacotherapy 
prior to angioplasty and stent placement is currently referred to as facilitated 
percutaneous coronary intervention, or FPC I. The results are rapid relief of angina, 
restoration of coronary and myocardial blood flow, improvement in myocardial 
preservation without significant risks of bleeding, and reduced incidence of death and 
reinfarction. 
The rationale for lytic therapy in conjunction with PCI and GP-IIb/llla inhibitors is that 
the earlier an infarct-related artery can be opened, the more myocardium can be 
preserved. Thrombolytic therapy initiated immediately in the field or in the emergency 
room can facilitate reperfusion before cardiac catheterization. A patent or partially patent 
artery would be technically easier to perform angioplasty and stenting on (Futterman & 
Lemberg 2000: 72-74). 
2.14 NEW AND UPCOMING TREATMENTS FOR ACS 
2.14.1 CONTINUOUS ST SEGMENT MONITORING 
The static 12-lead ECG is likely to miss important trends in ST -segment recover or 
reevaluation during the early dynamic period of ischemia, injury, or infaction because it 
documents electrical complexes of a single moment. Continuous ST -segment 
monitoring is a non-invasive, continuous method for monitoring coronary patency. 
Most current models of cardiac monitoring offer ST -segment monitoring capability, and 
stand-alone ST -segment monitors are also available, making continuous ST -segment 
monitoring accessible to everyone in all hospital locations. 
In addition to monitoring for reperfusion and reocclusion in ACS, ST -segment 
monitoring can help guide pharmacologic and mechanical intervention. Another 
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diagnostic advantage is that one can obtain an ECG immediately and concurrently with 
changes in pain. Most ST-segment monitoring systems can be set to capture a 12-lead 
ECG at 1- to 30-minute intervals and any time an alarm is triggered. These ECGs are 
plotted to form a trend, revealing ST -segment changes over time to help the nurse better 
asses her patient (Kucia & Stewart 2000: 4-13). 
2.14.2 PLAQUE STABILIZATION 
Research has shown that it is not necessarily the size of a plaque lesion, but rather the 
plaque composition that determines plaque stability. Studies have shown improved 
coronary and brachial endothelial function with several risk factor modifications and 
drugs that have also been shown to reduce cardiovascular events and ischemia in patients 
with coronary heart disease. These include cholesterol lowering, blood pressure 
reduction, smoking cessation, and administration of estrogen, ACE inhibitors, statins and 
antioxidant vitamins. These measures help stabilize existing plaque and prevent the 
occurrence offuture atherosclerotic lesions (Topoll998: 560-561). 
2.14.3 BIOCHEMICAL MARKERS OF INFLAMMATORY CELLS 
Pathological studies have revealed several common characteristics of plaques that have 
ruptured and caused clinical events. These features include a thin, fibrous cap; a large 
lipid core; numerous macrophages and other inflammatory cells; and a relative small 
number of vascular smooth muscle cells. Inflammatory cells can weaken the fibrous cap 
in several ways, leaving it vulnerable to rupture. Thus inflammatory cells can destroy the 
make-up of the fibrous cap. Researchers are working to establish reliable biochemical 
markers that will indicate the presence of these inflammatory cells at plaque sites and it 
is likely that biochemical measures of inflammation, along with measurement of 
conventional risk factors, will be used to guide the selection of patients at highest risk 
(Weissberg 2000: 247-252). 
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2.14.4 DETECTION OF PLAQUE PRESENCE AND COMPOSITION 
Magnetic resonance imaging (MRI), as mentioned earlier, gives anatomical detail, but 
no information on the inflammatory activity within the plaques. Positron emission 
tomography (PET) shows little anatomical information but gives the opportunity to 
measure and monitor plaque inflammatory cell content and activity. 
2.14.5 ORAL GP-IIb/llla INHIBITORS 
Although very expensive and still under research, it is hopeful that oral GP-llb/llla 
inhibitors can be developed for use for both in- and out-patient use to help prevent or 
treat ACS. These drugs block the final pathway of platelet aggregation and are currently 
the most effective antiplatelet medications on the market. 
2.14.6 COMBINATION DRUG THERAPY 
LMWHs and GP-IIb/llla drugs have been used separately either alone or in combination 
with other medications up until now to treat ACS. Randomized trials are now underway 
to test the effectiveness of using the two drugs concurrently to treat ACS. 
2.15 CONCLUSION 
Identifying and managing acute coronary syndromes (ACS) - unstable angina, non-Q-
wave and Q-wave Mls- is a challenge for nurses. The goal of therapy is to maintain 
perfusion through the coronary arteries while limiting any areas of myocardial damage. 
The whole spectrum of ACS has been investigated thoroughly in recent decades and have 
resulted in in-depth knowledge of the pathophysiology and in extensive experience with 
different treatment methods. In addition to being familiar with current approaches to 
treating ACS, it is vitally important that the critical care nurse have a thorough 
knowledge of the pathophysiology of ACS in order to understand the rationale behind 
approaches to treating ACS. 
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CHAPTER3 
RESEARCH DESIGN AND RESEARCH METHODOLOGY 
3.1 INTRODUCTION 
The research design and method are discussed in detail in this chapter. The aim of this 
study is reiterated for clarity purposes, which was to explore and describe the 
respondents' perceptions as to how they rate their knowledge of ACS, the 
pathophysiology of ACS and current approaches to and rationales for treatment, and 
based on the results of the findings, to formulate an in-service training session about ACS 
for critical care nurses. Table 3.1 on page 52 is a summary of the content. 
Table 3.1 Research Design and Method 
AIM DATA SAMPLING& VALIDITY & DATA 
GATHERING POPULATION RELIABILITY ANALYSIS 
Explore and descn"be Implementation Convenience sample Literature review, Descriptive and 
the respondents' of a ofvoluntary critical professional inferential 
perceptions as to how questionnaire care nurses of all experts' critique, statistics. 
they rate their qualifications, Cronbach' s alpha 
knowledge regarding regardless of staff and factor 
aspects of ACS: its appointment, in a analysis. 
pathophysiology, state hospital in East 
current available Texas. 
treatments, rationales 
for such treatments 
and nursing care, and 
to formulate an in-
service training 
session on ACS. 
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3.2 RESEARCH DESIGN AND METHOD 
3.2.1 RESEARCH DESIGN 
The design of this research study was a quantitative, descriptive and contextual study in 
which a sample survey was performed: 
0 The study is quantitative in order to investigate the perceptions of critical 
or acute care nurses as to how they rate their knowledge regarding ACS, 
and also to access the magnitude and reliability of relationships between 
independent variables and nurses' knowledge of ACS (Polit & Hunger 
1995: 651). 
0 It is descriptive because it aims at describing and documenting 
phenomena, such as the respondents' age, number of years nursing 
experience and education for this specific context (Polit & Hunger 1995: 
52, 178). 
0 It is contextual because this study focuses on the knowledge of critical 
care nurses regarding ACS and specifically the critical care nurses at a 
state hospital in East Texas. 
As instrument a questionnaire was used to describe the critical or acute care nurses' 
rating oftheir knowledge of ACS. Scales were chosen for answering questions instead of 
using open-ended questions. The reason for this is because the researcher assumed that 
with scales, the participants could indicate what they perceived they knew regarding 
ACS, and this would be less threatening to them than open- or close-ended questions, in 
which their knowledge about ACS would actually be tested. 
In a survey information from populations regarding the prevalence, distribution, and 
interrelations of variables can be obtained within those populations. One of the greatest 
advantages of survey research is its flexibility and broadness of scope. It can be applied 
to many populations, it can focus on a wide range of topics, and its information can be 
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used for many purposes. Questionnaires in particular are easy to administer and 
economical (Polit & Hunger 1995: 187-188).Questionnaires are self-administered, i.e. 
the same respondent reads the questions on a form and gives an answer in writing. 
Care was taken in the development of the questionnaire to word the questions clearly, 
simply and unambiguously. The specific context in which this research study was held 
was in a state hospital in East Texas affiliated with the University of Texas. 
3.2.2 RESEARCH METHOD 
The purpose of the literature study was three-fold: first, to establish a conceptual 
framework for the research study; secondly, to identifY the criteria to be considered as 
critical points for this study, and thirdly, to formulate an educational in-service training 
session on ACS for critical care nurses in the hospital where this study is performed. 
3.2.2.1 DATA GATHERING 
The data was gathered by means of a questionnaire. The development of the 
questionnaire was as follows: 
0 development phase 
0 types of questions 
0 refinement of questionnaire 
0 confirmation phase 
Development phase 
The literature study was used to determine which criteria were to be considered as critical 
points in the study. The questionnaire using scales was chosen by the researcher because 
it is not expensive, it requires less time to administer compared to other types of data 
collection methods, and it provides the possibility of complete anonymity (Burns & 
Grove 1993: 374). 
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A cover letter (see Annexure I) accompanied the questionnaire, explaining the purpose 
of the study, the name of the researcher, and assuring anonymity. 
Types of questions 
All the questions regarding the respondents' knowledge in the second section are of such 
a nature that the respondent had to evaluate him/herself on a rating scale. The reason for 
using these kinds of questions is that graded alternatives give the researcher more 
information regarding intensity as well as direction of opinion. It also gives the 
respondents the opportunity to express a range of views (Burns & Grove 1993: 377-379; 
Polit & Hungler 1995: 256, 277). The respondents do not feel threatened by the 
questions - in other words, they do not feel that somebody is checking on what they 
know or do not know about ACS. They are actually rating or evaluating their own 
knowledge, which contributes to a non-threatening situation. Scales are popular amongst 
nurse researchers, are easy to administer, and do not require a group of expert judges to 
put together the questions (Abdellah & Levine 1979: 260-262; Polit & Hungler 1984: 
281-283). The questions in ~ection one regarding demographic general information are a 
combination of fill-in-the-blank and multiple-choice questions. 
Compilation of questionnaires 
The questionnaire (see Annexure II) consists of two sections. The first section covers 
general information about the respondents. The second section covers information about 
ACS. Table 3.2 gives a layout of the questionnaire. 
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Table 3.2 Layout of Questionnaire 
SECTION TOPIC NUMBER & DESCRIPTION OF QUESTION 
1- General Demographic Seven questions: 1-7 
information data Age, gender, marital status, level of education, staff appointment, 
number of years nursing experience in general and number of 
years critical care nursing experience. This data was used to 
describe the sample population. Additionally, this study looks at 
relationships between these independent variables (demographic 
data) and the opinion of the respondents on their level of 
knowledge of ACS as portrayed by the answers to the 
questionnaire. 
2- Definition of One question: 1 
Knowledge ACS Describes the opinion of the respondents on their level of 
ofACS understanding of the definition of ACS. 
Pathophysio1- One question: 2 
ogyofACS Reflects the opinion of the respondents on their ability to 
describe the pathophysiology of ACS to patients 
Patient One question: 3 
education Reflects the opinion of the respondents on their ability to explain 
regarding in- to patients about non-invasive and invasive treatments performed 
hospital in the hospital aimed at managing ACS. 
management 
ofACS 
Physiology of One question: 4 
clot Describes how the respondents feel they would benefit from an 
formation and understanding of the physiology of thrombus formation and 
lysis. lysis. 
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NUMBER & DESCRIPTION OF QUESTION 
How Two questions: 5 and 6 
hypertension Reflects the opinion of the respondents on the level of their 
can lead to understanding of how hypertension can lead to endothelial 
ACS damage, plaque formation, plaque rupture and thrombus 
formation, and their ability to explain this to the patients. 
Q-wave and One question: 7 
non-Q-wave Reflects the opinion of the respondents regarding their 
MI knowledge about the differences between a Q-wave and non-Q-
-~~. I 
Unstable One question: 8 
angmaora Describes the opinion of the respondents on their knowledge of 
non-Q-wave how unstable angina or a non-Q-wave MI can progress to an 
MI acute MI. 
progressing 
to an acute 
MI. 
Cardiac Three questions: 9, 10, 11 
markers. Reflects the opinion of the respondents on their knowledge about 
the three main cardiac markers, how to explain their 
interpretation to patients, and the respondents' knowledge about 
the advantages and disadvantages of each cardiac marker in 
diagnosing a MI. 
ECG One question: 12 
readings. Descn"bes the opinion ofthe respondents on their understanding 
of what ECG changes indicate myocardial ischemia, injury and 
infarction. 
Sheath One question: 13 
removal Reflects the respondents' opinion on their level of experience in 
sheath removal after PCI. 
58 
NUMBER & DESCRIPTION OF QUESTION 
Low One question: 14 
molecular Describes the respondents' opinion on their level ofknowledge 
weight regarding drug actions ofLMWH and advantages and 
heparins disadvantages of using LMWH instead of un:fractioned heparin. 
(LMWH) 
Glycoprotein Three questions: 15, 16, 17 
Ilblllla Reflects the opinion of the respondents on their level of 
inhibitor knowledge about the use of GB Ilblllla drugs for treating 
agents unstable angina and non-Q-wave :MI, their level of experience in 
administering these agents, and their level ofknowledge about 
how these agents are used after PTCA/stent procedures. 
Thrombolytic Three questions: 18, 19, 20 
agents Reflects the opinion of the respondents· on their level of 
knowledge about actions, uses and potential complications of 
administering thrombolytic agents, as well as describes their 
level of knowledge of the contraindications to giving 
thrombolytics and/or llb!IIIa inhibitor agents. 
Beta-blockers One question: 21 
Describes the opinion of the respondents on their level of 
knowledge on the rationale of administration of beta-blockers to 
patients who have recently experienced a :MI. 
Regularity of One question: 22 
patient Describes the respondents' regularity in providing patients 
education education regarding ACS pathophysiology and medications used 
to treat ACS. 
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NUMBER & DESCRIPTION OF QUESTION 
Medications Two questions: 23 and 24. 
for ACS Reflects the opinion of the respondents on their level of 
patients knowledge about several medications prescribed for ACS 
patients (calcium channel blockers, long-acting nitrates, beta-
blockers, angiotension-converting enzyme (ACE) 
inhibitors,aspirin, clopidogre~ ticlopidine and warfarin) at time 
of hospital discharge, as well as the respondents' ability to 
explain the uses and side effects of these drugs to their patients. 
Refinement of questionnaire 
The critical care nurse educator at the hospital where this study was performed was 
approached and agreed to be of assistance to review the questionnaire. She has extensive 
expertise in intensive care nursing as well as critical care education. Changes to the 
questionnaire were made according to her suggestions. 
Confirmation phase 
The questionnaire was revised and presented to the Nurse Executive at the hospital for 
approval of distribution (see Annexure III: Permission Letter) .. 
3.2.2.2 POPULATION AND SAMPLING 
Population 
The target population was the critical or acute care nurses at a state hospital in East 
Texas. This included nurses working in the Intensive Care Unit (ICU), Operating Room 
(OR), Emergency Room (ER), Cardiac Catheterization Laboratory (cath lab), and 
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Telemetry (5 East). The nurses working in these units during the month ofMay 2000 
were asked to take part in this study. They participated regardless of their critical care 
training and experience status. Full-time, part-time and PRN (session) staff were 
included in this study. This hospital was chosen because the researcher works there, and 
was interested to know how much those working with her know about ACS. She also 
wants to help them increase their knowledge about ACS and help them improve their 
nursing care for such patients. Written permission was obtained to from nursing 
management ofthis hospital to distribute the questionnaire (see Annexure Ill). 
Sampling 
Convenience sampling was used in this research. Convenience sampling entails the use 
of the most conveniently available people for use as subjects in a study. An advantage is 
that it is inexpensive. A weakness in this method is that available subjects may be 
atypical of the population in regards to the critical variables being measured. This can 
limit the extent of generalization (Polit & Hunger 1995: 232). The questionnaires were 
put in the critical care nurses' mailboxes of the units mentioned above. Instructions were 
given on the cover sheet for the nurse to fill out the questionnaire at work and to return it 
to a large manila envelope conveniently posted in each unit for collection of the 
questionnaires. Seventy questionnaires were passed out. A total of25 were returned, but 
only 19 were completely filled out (n=19). 
3.2.2.3 VALIDITY AND RELIABILITY 
Validity refers to ''the degree to which an instrument measures what it is supposed to be 
measuring". Internal validity is ''the degree to which it can be inferred that the 
experimental treatment (independent variables), rather than uncontrolled, extraneous 
factors, is responsible for observed effects". External validity refers to how well the 
research findings can be generalized to other settings or samples (Po lit & Hunger 1995: 
353, 644). Reliability refers to the degree of consistency with which the instrument (in 
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this case, the questionnaire) measures the thing it is supposed to be measuring 
(knowledge of ACS). 
The questionnaire is a product of the literature study, conceptual framework and the 
contribution of professionals. Its validity was confinned by the evaluation of the 
professionals mentioned earlier. In addition, the researcher did not bias her scale. As 
indicated earlier by the researcher, critical thinking is vitally important to the nursing 
process and will resuh in a comprehensive plan of care for patients with the most 
potential for success. The researcher assumes that in order to provide optimum care for 
ACS patients, the nurse must be able to make independent judgments and decisions 
which arise from a sound knowledge base and the ability to integrate that knowledge of 
information within the context where it is applied (in this case, critical care hospital 
units). Additionally, clinical practice expertise-- developed through clinical experience--
is a very important element influencing the nursing process and is what consistently 
characterizes the nurse expert (Thelan et al1994:4). 
Internal validity was not easy to maintain. The researcher could only assume the 
participants answered the questions honestly. However, the non-threatening nature ofthe 
questions and assured anonymity and confidentiality could have enhanced honesty. 
External validity "is concerned with the extent to which study findings can be generalized 
beyond the sample used in the study" (Burns & Grove 1993). It was not achieved in this 
study, because the researcher was not able to control the rate of return of the 
questionnaires, which may be a factor in the low rate of return. Out of70 questionnaires 
distributed, only 25 were returned, and only 19 of those returned were completely filled 
out. It can be further mentioned that looking at the demographic data, the mean age was 
47 years and the mean nursing experience was 18 years, of which both are probably 
higher than at many other hospitals. The hospital where this research study was 
performed is a state hospital that has excellent benefits - vacations, health insurance, and 
pension plans- which is a major reason why employees remain working at this 
institution over long periods of time. 
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Reliability of the questionnaire was confirmed by Cronbach's alpha and factor analysis. 
This was determined before the questionnaire was distributed. Cronbach's alpha is a 
widely used method to determine internal consistency of the instrument used in a 
research study. In other words, it measures whether or not items in the instrument 
correlate with each other. The normal range of values is between 0.0 and+ 1.0, and 
higher values reflect a higher degree of internal consistency. In the case of this study, 
Cronbach's alpha was 0.9416, reflecting a high degree of internal consistency, i.e. a high 
degree of correlation between the subject items in the questionnaire. This means there is 
consistency in what the items measure - they measure what they are supposed to measure 
(Abdellah & Levine 1979: 281-283; Polit & Hunger 1984: 347-351). 
3.2.2.4 METHOD OF DATA COLLECTION 
Data collection 
Before approaching the Nurse Executive for permission to run this study, the researcher 
approached the I CU manager and the critical care nurse educator. The researcher 
explained the purposes of this study and presented the questionnaire along with an outline 
of a proposed in-service training session on ACS to be given. Anonymity and 
confidentiality of each participant were assured, as any information collected would not 
be linked in any way to their names. 
Each nurse has his/her own mailbox at the hospital, and a questionnaire was placed in the 
mailboxes of all nurses working in the ICU, OR, ER, cath lab and 5 East. A large manila 
envelope marked "ACS Questionnaires" for collection of the questionnaires was placed 
in each of the five units and instructions given to the nurses to fill out the questionnaire at 
work and return it to the designated manila envelope posted in their respective unit. This 
set of instructions could also have contributed to reliability. The questionnaires were 
distributed during the first week of May 2000 and the collection envelopes were picked 
63 
up at the end ofMay 2000. Out of70 questionnaires distributed a total of25 were 
returned. Only 19 ofthese 25 questionnaires were :filled out completely. 
Control of external variables 
Control of external variables in this study was not strict. The questionnaires were placed 
in respondents' mailboxes and they were given almost a month's time in which to return 
them to the collection envelopes. However, in this questionnaire knowledge was not 
tested. The respondents had to rate their knowledge on a scale, which eliminated the 
need amongst the respondents to share knowledge as would have been the case in order 
to perform better in a ''test" type questionnaire. For the same reason, the respondents 
would not have taken the questionnaires home with them and/or consuhed outside 
sources of information for the answers, because they only had to give an opinion on how 
they rate their own knowledge. The researcher was available during work hours for 
answering any queries. 
Additional to the above, the questionnaire was developed by the researcher after a 
thorough literature study was done on the subject of ACS. A literature review helps a 
researcher develop a broad conceptual context into which a research problem will fit, and 
also serves to provide the researcher with a perspective on the problem necessary for 
interpreting the results ofhislher study (Polit & Hungler 1995: 70). 
Indicators of adequate competency 
A standardized answer sheet was used for retrospective evaluation of the questionnaire. 
In 22 of the 24 questions, circling "1) (strongly agree) is an indication that the respondent 
believes he/she has a thorough understanding of what is asked. Two out of the 24 
questions (4 and 15) are the reverse: by answering with a "7" (strongly disagree) the 
respondent indicates he believes he/she has a thorough understanding of what is asked. 
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3.2.2.5 DATA ANALYSIS 
Data analysis was done by means of descriptive and inferential statistics. Descriptive 
statistics were used to document and describe responses on the questionnaire, including 
what percentage of critical care nurses displayed competency in each area measured. 
Inferential statistics were used to infer relationships between the independent variables 
(age of respondents, number of years nursing experience, number of years critical care 
nursing experience, educational level of respondents) and the respondents' perception as 
to how they rate their knowledge regarding ACS. 
3.3 SUMMARY 
The design of this research study was a quantitative, descriptive and contextual study. A 
questionnaire was used as an instrument to ascertain the opinion or perception of the 
respondents on their knowledge about ACS. Convenience sampling was used. The . 
questionnaire was a product of a literature study, conceptual framework, and contribution 
of professionals. 
Reliability was measured by Cronbach's alpha and factor analysis before the 
questionnaire was distributed. Control of external variables was explained. The rate of 
return of the questionnaires was low, given the number originally distributed in the 
nurses' mailboxes. 
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CHAPTER4 
RESULTS OF THE STUDY 
4.1 INTRODUCTION 
The resuhs of this research study are presented and discussed in this chapter. Where 
possible, data has been presented in tables to clarify and simplifY the results. The 
competency indicator will be reviewed, followed by a description of the participants of 
the research study. The data analysis is presented in different sections: analysis of the 
complete scale, percentages of participants having adequate knowledge in each subject 
area, and correlational analysis between the independent variables (age, years nursing 
experience, years critical care nursing experience, and level of education and the test 
scores). 
4.2 COMPETENCY SCORES 
Critical or acute care nurses are highly specialized nurses, and the researcher assumes 
that they have a solid knowledge of critical care nursing in order to provide the skills and 
competent intensive care for patients whose conditions may change rapidly and who 
require both close monitoring and critical care intervention. Critical care nurses ought to, 
ideally, know the pathophysiology of coronary artery disease and understand the rapidly 
evolving treatments for ACS. 
Competency, or adequate knowledge of a respondent in his/her opinion regarding a 
particular subject area, is indicated by circling a "1" (strongly agree) or a "2" (agree) in 
all questions except questions 4 and 15, in which case it is the reverse- circling a "6" 
(disagree) or "7" (strongly disagree) indicates adequate knowledge/competency regarding 
the area questioned. 
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4.3 PARTICPANTS IN THE RESEARCH STUDY 
4.3.1 DEMOGRAPHIC INFORMATION 
Table 4.1 outlines the demographic profile of the respondents. Of the 19 respondents, 17 
were female, and 14 were married. The largest number of nurses had an ADN (three-
year registered nurse Associate Degree ofNursing), and seven had a BSN (four-year 
registered nurse Bachelor Degree of Science in Nursing). Two nurses had a Master's 
degree. The largest number of nurses (eight) work in ICU, with seven working in ER, 
three in 5-East {Telemetry), and one in the cardiac catheterization laboratory (cath lab). 
No one from OR returned a questionnaire. 
The mean age was 47 years old, and the mean number of years nursing experience was 
18 years. The mean number ofyears experience in critical care nursing was 8 years. 
Table 4.1 Demographic Profile of Participants 
Sample size (N): 19 
Gender 
Male 2 
Female 17 
Education level 
ADN 11 
BSN 7 
MA,MN,MSN I 
PhD 0 
Mean age: 4 7 years 
Mean number of years nursing 
experience: 18 years 
Mean number of years critical care 
nursing experience: 8 years 
Marital status 
Married 14 
Single 0 
Divorced 5 
Widowed 0 
Unit worked 
ICU 
ER 
OR 
Cath lab 
5 East 
8 
7 
0 
1 
3 
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Table 4.2 shows the mean age level and the mean number of years experience in nursing 
and in critical care nursing in the ADN group (n=11) and the BSN/MSN group (n=8). 
The BSN and MSN nurses were grouped together for simplicity's sake, partly because of 
such a small number (one) ofMSN nurses, but mainly because a BSN is the basic 
requirement before continuing on to a MSN. The means in the two groups were very 
similar. The mean age of ADN nurses was 46 years, and the mean age ofBSN/MSN 
nurses was 44 years. The mean number of years nursing experience for ADN nurses was 
11 years and the mean for BSN/MSN was 8 years. The mean number ofyears critical 
care nursing experience for ADN nurses was 11 years and the mean for BSN/MSN nurses 
was 8 years. 
Table 4.2 The mean age, years nursing experience and years critical care nursing 
experience with regards to educational level 
ADNNurses BSN/MSN Nurses 
Variable N Mean N Mean 
Age 11 47 ·8 45 
Years nursing 11 18 8 19 
experience 
Years critical care 11 10 8 9 
nursing experience 
Table 4.3 shows a further breakdown regarding educational level, showing how many 
registered nurses work in the different critical care units studied. Of the 8 nurses working 
in ICU, 75% of them (6) were ADN nurses. Of the 7 working in ER, a greater 
percentage, 57% ( 4) were BSN/MSN nurses, versus 43% (3) who were ADN nurses. The 
nurse from the cath lab was an ADN nurse. Of the three (3) registered nurses working in 
5-East, 2 of them were BSN/MSN nurses and 1 was an ADN nurse. 
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Table 4.3 The number of nurses working in specific units with regards to educational 
level 
Educational data Units Where Nurses Work 
ICU ER CATH 5 East Total 
Number ADN nurses 6 3 1 1 11 
Percentage ADN nurses 75% 42.86% 100% 33.33% 57.89% 
Number BSN/MSN nurses 2 4 0 2 8 
Percentage ADN/BSN nurses 42.11% 57.14% 0% 66.67% 42.11% 
Total number 8 7 1 3 19 
Total Percentage 42.11% 36.84% 5.26% 15.79% 100% 
4.4 ANALYSIS OF THE DATA 
4.4.1 ANALYSIS OF THE COMPLETE SCALE 
Table 4.4 shows an analysis of the complete scale. The sample size, n=19, reflects the 
number of participants who filled out the questionnaire entirely. This table shows the 
mean score for each question. A mean score is computed by summing all the scores for 
each question and dividing by the number of subjects (participants). The lowest score 
recorded is question 12, with a mean score of2.76 (note: question 4 has a mean score of 
2.16, but as mentioned before, in this question and in question 15, adequate knowledge 
would be indicated by a "6" or a "7", not a "1" or "2" as in the other questions). These 
averages indicate that as a whole sample, adequate knowledge and expertise does not 
occur in regards to any area questioned. 
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Table 4.4 
Analysis of Complete Scale 
Question Sample 
01 
02 
03 
04 
05 
06 
07 
08 
09 
010 
011 
012 
013 
014 
015 
016 
017 
018 
019 
020 
021 
022 
023 
024 
Reliability 
Chronbach's Alpha 
Principle Component Analysis 
One Factor 
Size 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
19 
. 19. 
19 
19 
19 
Variance Accounted for 
.9416 
.4537 
Mean Standard 
Deviation 
2.89 1.20 
3.16 1.30 
3.05 1.13 
2.16 1.21 
3.00 1.29 
3.16 1.30 
3.11 1.29 
3.21 1.13 
3.16 1.71 
2.95 1.35 
3.89 1.20 
2.76 0.93 
3.89 2.34 
3.58 1.46 
2.79 1.65 
3.89 1.76 
4.00 1.80 
3.16 1.26 
2.84 1.42 
2.95 1.48 
3.47 1.47 
3.63 1.32 
3.68 1.34 
3.68 1.45 
4.4.2 PERCENTAGES OF CRITICAL CARE NURSES HAVING ADEQUATE 
KNOWLEDGE IN THEIR OPINION 
Table 4.5 shows the percentage of respondents having adequate knowledge/expertise in 
their opinion regarding individual subject areas tested. The topic is listed with the 
questions relevant to that topic, along with the number of nurses and corresponding 
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percentage who scored a "1" or "2" (or a "6" or "7" in questions 4 and 15) indicating 
competency in their opinion. 
This table indicates that only in one area do more than 50% of the respondents have 
adequate knowledge in their opinion, and that is in the subject of thrombolytic agents 
(53% ofthe respondents in question 19). In all the other questions, the percentage of 
respondents having adequate knowledge in their opinion regarding ACS ranges from 0 to 
4 7%, reflecting an overall knowledge deficit regarding ACS amongst the participants. 
Table 4.5 Percentage of nurses having adequate knowledge in their opinion regarding 
individual subject areas. 
Topic 
Definition of ACS , 
Pathophysiology of 
ACS 
Patient education 
regarding in-hospital 
management of ACS. 
Question, number and percentage of respondents having 
adequate knowledge in their opinion regarding individual 
topics of ACS 
Question: 1 
19 Respondents answered this question. Nine or 4 7% of the 
respondents are of the opinion they understand the definition of 
ACS 
Question: 2 
19 Respondents answered this question. Seven or 37% ofthe 
respondents are of the opinion they are able to explain to their 
patients the pathophysiology of ACS. 
Question: 3 
19 Respondents answered this question. Six or 32% ofthe 
respondents are of the opinion that they can competently 
explain in-hospital management of ACS to their patients. 
Physiology of clot 
formation 
How hyptertension 
leads to ACS 
Q-wave and non-Q-
waveMI 
Progression of 
unstable angina or 
non-Q-wave MI to 
acute MI. 
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Question, number and percentage of respondents having 
adequate knowledge in their opinion regarding individual 
topics of ACS 
Question: 4 
19 Respondents answered this question. None ofthe 
respondents are of the opinion that they have an adequate 
knowledge of the physiology of clot formation. They would all 
benefit to know more about it. 
Question: 5 and 6 
Question 5: 19 Respondents answered this question. Four or 
21% are of the opinion that they have an adequate 
understanding of how chronic hypertension can lead to 
endothelial damage, progressing to plaque formation, plaque 
rupture and thrombus formation. 
Question 6: 19 Respondents answered this question. Five or 
26% are of the opinion that they are able to explain to their 
patients why chronic hypertension can lead to endothelial 
damage, progressing to plaque formation, plaque rupture and 
thrombus formation. 
Question: 7 
19 Respondents answered this question. Seven or 37% are of 
the opinion that they have an adequate knowledge regarding the 
difference between a Q-wave and non-Q-wave MI. 
Question: 8 
19 Respondents answered this question. Four or 21% are ofthe 
opinion that they adequately understand what factors contribute 
toward causing unstable angina or non-Q-wave MI to progress 
to an acute MI. 
Cardiac markers 
ECG readings 
Sheath removal 
Low molecular weight 
heparin 
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Question, number and percentage of respondents having 
adequate knowledge in their opinion regarding individual 
topics of ACS. 
Question: 9, 10, 11 
Question 9: 19 Respondents answered this question. Eight or 
42% are of the opinion that they have adequate knowledge 
regarding the cardiac markers myoglobin, CPK-MB and 
Troponin (I and T), and are able to interpret these tests 
correctly. 
Question 10: 19 Respondents answered this question. Eight or 
42% are of the opinion that they are able to adequately explain 
to their patients the interpretation of cardiac marker values. 
Question 11 : 19 Respondents answered this question. None are 
of the opinion that they adequately understand the advantages 
and disadvantages of the cardiac markers in diagnosing a non-
.Q-wave and a Q-wave MI. 
Question: 12 
19 Respondents answered this question. Nine or 47% are ofthe 
opinion that they have adequate knowledge regarding ST 
segment and T -wave changes indicative of myocardial 
ischemia, injury and infarction 
Question: 13 
19 Respondents answered this question. Seven or 37% are of 
the opinion that they are experienced in sheath removal. 
Question: 14 
19 Respondents answered this question. Four or 21% are ofthe 
opinion that they have adequate knowledge regarding the drug 
actions ofLMWH and understand the advantages and 
disadvantages ofusing them verses heparin. 
GB lib/Ilia inhibitors 
Thrombolytic agents 
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Question, number and percentage of respondents having 
adequate knowledge in their opinion regarding individual 
topics of ACS. 
Question: 15, 16, 17 
Question 15: 19 Respondents answered this question. Three or 
16% are of the opinion that they have adequate knowledge 
regarding GB Ila/IIIb inhibitors and their use in treating 
unstable angina and non-Q-wave MI. 
Question 16: 19 Respondents answered this question. Six or 
32% have administered GB lib/Ilia inhibitors after PCI and 
stent procedures and are ofthe opinion that they have an 
adequate understanding of the rationale for the use of these 
drugs. 
Question 17: 19 Respondents answered this question. Five or 
26% are of the opinion that they are able to adequately explain 
·to their patients the rationale for using GB lib/Ilia inhibitors 
after PCI procedures. 
Question: 18, 19, 20 
Question 18: 19 Respondents answered this question. Seven or 
37% are of the opinion that they have adequate knowledge 
regarding the therapeutic actions and indications for 
thrombolytic agents. 
Question 19: 19 Respondents answered this question. Ten or 
53% are of the opinion that they have adequate knowledge of, 
and are able to recognize, potential complications arising from 
the use ofthrombolytic agents. 
Question 20: 19 Respondents answered this question. Nine or 
47% are of the opinion that they have adequate knowledge 
regarding contraindications of administering thrombolytics 
and/or GB IIb/IIIa inhibitors. 
Beta-blockers 
Regularity of patient 
education 
Medications for ACS 
patients 
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Question, number and percentage of respondents having 
adequate knowledge in their opinion regarding individual 
topics of ACS. 
Question: 21 
19 Respondents answered this question. Five or 26% are ofthe 
opinion that they have adequate knowledge regarding the 
rationale for administering beta-blockers to patients who have 
recently undergone a MI. 
Question: 22 
19 Respondents answered this question. Three or 16% 
regularly provide education to their patients regarding ACS 
pathophysiology and the medications used to treat ACS. 
Question: 23, 24 
Question 23: 19 Respondents answered this question. Two or 
11% are of the opinion that they have adequate knowledge 
· regarding the drug actions and uses for certain medications 
prescribed for ACS patients being discharged from the hospital. 
Medications include: calcium-channel blockers, long-acting 
nitrates, beta-blockers, ACE inhibitors, ASA, clopidogrel, 
ticlopidine and warfarin. 
Question 24: 19 Respondents answered this question. Three or 
16% are of the opinion that they able to adequately explain to 
their patients before discharge the uses and side effects of the 
medications listed in question 23. 
4.4.3 CORRELATIONAL ANALYSIS 
Annexure W, The Correlational Analysis, is a detailed breakdown illustrating the 
correlation between three of the independent variables, namely age, number of years 
75 
nursing experience, and number of years critical care nursing experience as well as the 
scores on each question. The level of significance (p-value) in such an analysis is an 
index ofhow probable it is that the findings are reliable. In other words, significance 
means that '"the obtained results are unlikely to have been the result of chance (Po lit & 
Hunger 1994: 408). For example, if a report indicates that a finding was significant at the 
0.05 level, that means that only 5 times out of 100 would the obtained result be haphazard 
or due to chance. A nonsignificant result indicates that the result could have occurred as 
a result of chance. This analysis reflects that, out of75 different findings, only 11ofthem 
were found to be significant. Significance in this study = p-value less than/equal to 0.16. 
Normally if a p-value is less than .05 it is said to be significant. However, in this 
research study, because the sample size was small, significance must be judged 
differently, and if the p-value was less than or equal to 0.16, it could be said that a trend 
toward significance occurred. 
Of the 11 significant findings, two have positive relationships (question 4 and 22). A 
positive relationship between two variables exists when there is a tendency for high 
values on one variable to be associated with high values on the other. In question 4, as 
age increases, the respondents' scores increase. In the case of this particular question, 
this means that increased age correlates with the respondents' opinion that they would not 
benefit from a thorough understanding of clot formation and lysis physiology. In other 
words, the older a respondent, the more he/she is of the opinion that he understands clot 
formation and lysis physiology and does not need further understanding. In question 22, 
as the years of nursing experience increase, so do the respondents' scores increase, 
indicating that the more years nursing experience the respondents have, the less regularly 
they provide patient education to patients diagnosed with unstable angina, non-Q-wave 
and Q-wave MI. The other 9 significant findings have negative (inverse) relationships, 
indicating that as the variable amount decreases, the scores increase. 
It is interesting to note that the smallest p-values (where pis less than 0.01 and pis less 
than 0.05 correspond with questions 19 and 20 respectively) correlate with the findings in 
Table 4.5 in which the highest percentage of respondents who feel they have adequate 
76 
knowledge regarding ACS was also found to be in questions 19 and 20 (57% of the 
nurses had adequate knowledge regarding thrombolytic agents in these two questions). 
This emphasizes that thrombolytic agents is the subject area about which most of the 
nurses feel they are most knowledgeable. 
It should also be noted that of the 11 significant findings, 7 of them indicate that as the 
number of years critical or acute care nursing experience increased, so did the 
respondents rate their adequacy of knowledge regarding ACS. The researcher assumed 
before conducting this study that this would be true. 
With so few findings significant, it is safe to say that age, number of years nursing 
experience and number of years critical or acute care nursing experience did not have an 
impact on the scores, i.e. there is no significant correlation between the questionnaire 
scores and these three independent variables. This apparent trend could possibly be due 
to the small sample size. Typically a larger sample size will increase the probability of 
the findings being significant. However, let it be noted that the number of years critical 
care nursing experience has the most impact on score values in this analysis. 
4.4.4 EFFECT OF EDUCATIONAL LEVEL ON SCORES 
Annexure V, The Effect of Education Level on the Total Scale and Individual 
Questions, displays the mean scores of the total scale and the individual questions and 
reflects whether or not there is significance between the scores and the nurses' level of 
education. Normally when comparing two groups, one uses at-test. However, ANOVA 
(analysis of variance), which was used in this analysis, is an alternative tot-test. F-value 
is a statistic resulting from ANOVA, and the p-value is derived from the F-value. Ofthe 
25 findings reported, 9 (36%) are significant (where p-value is less than or equal to 0.16). 
With 36% of the findings significant, the researcher concludes there is a trend toward the 
level of education significantly influencing the overall scores. 
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In every one of these significant findings, with the exception of one (question 1 ), a lower 
score corresponds with the ADN nurses, indicating that the ADN nurses were more of the 
opinion that they had adequate knowledge. The researcher expected the opposite would 
occur. ADN nurses graduate from a two-year associate degree of nursing school (all 
prerequisites must be completed before entering the nursing program). BSN nurses 
graduate from a more rigorous and demanding four-year university nursing program. 
The researcher expected the BSN group to be the ones perceiving they have adequate 
knowledge regarding ACS, which turned out not to be the case in these findings. 
4.5 SUMMARY 
Both the analysis ofthe complete scale and the analysis ofthe percentages of respondents 
having adequate knowledge individual subject areas reflect an overall knowledge deficit 
amongst the participants regarding ACS in their opinion. Thrombolytic agents appear to 
be the subject that the respondents feel they are most knowledgeable about. Age and 
years of general nursing experience did not impact scores in any significant way. 
However, the number of years critical or acute care nursing experience did have a 
significant impact, which the researcher had predicted. The level of education appeared 
to have a significant impact on scores, but surprisingly, the group with the lesser amount 
of education (ADN nurses) scored better than the group with a longer, more demanding 
education (BSN nurses). 
With these findings in mind, an educational in-service on ACS will be prepared and 
given to the critical or acute care nurses at the hospital where the study was performed. 
All content to be taught will be reviewed first by the hospital's critical care nurse 
educator and one other critical care nurse with extensive cardiovascular intensive care 
nursing experience. Attendance will be voluntary. 4.2 hours of continuing nursing 
education will be awarded to each participant upon completion of the class. The goal of 
this in-service training session is to broaden and deepen critical care nurses' knowledge 
base of ACS so they may make more informed independent judgments, resulting in 
improved nursing care. 
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CHAPTERS 
CONCLUSIONS, RECOMMENDATIONS AND GUIDELINES 
FOR IN-SERVICE TRAINING SESSION 
5.1 INTRODUCTION 
The researcher's interest in cardiac nursing and the interest to discover how much critical 
or acute care nurses feel they know about ACS motivated the researcher to undertake this 
study. A literature study was subsequently completed and a research tool developed: a 
questionnaire with a rating scale. 
The implementation of the questionnaire was done by the researcher. The data was 
processed and presented in the previous chapter. The goal of this study was twofold: 
first, to explore and describe the opinion of critical or acute care nurses in a specific 
setting regarding their knowledge of ACS, and secondly, to develop a four-hour in-
service training session on ACS for all critical care nurses where this research study was 
performed. This chapter is concerned with recommendations and presenting an outline of 
the final goal, formulating an in-service presentation on ACS for critical care nurses. 
5.2 CONCLUSIONS 
The conclusions are divided up into demographic data and knowledge level. 
5.2.1 DEMOGRAPHIC DATA 
0 The participants were full-time or part-time staff in one offour critical care units: 
ICU, ER, cath lab and 5-East (Telemetry). 
0 The mean age ofthe participants was 47 years old. The mean number of years 
nursing experience was 18 years, and the mean number of years critical care 
nursing experience was 8 years. 
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0 One ( 1) nurse had a master's degree level of education. Of 18 registered nurses, 7 
had a BSN degree and 11 had an ADN degree. 
0 75% of the respondents working in ICU who filled out the questionnaires were 
registered nurses who had ADN degrees, whereas 66% of the registered nurses 
working in 5-East (Telemetry) who filled out the questionnaires had a BSN or 
MSN degree. Slightly more than half(57%) ofthe nurses working in ER had a 
BSN or MSN degree, and the one nurse from the cath lab had an ADN degree. 
5.2.2 KNOWLEDGE LEVEL 
Critical or acute care nursing involves the use ofhigh-level critical thinking skills within 
the nursing process, and a sound knowledge base is vital to independent judgments and 
decision making. If the nurse has a knowledge deficit in a particular area, his/her ability 
to think critically and make the necessary clinical decisions will be hindered. She will 
not have a thorough knowledge ofthe disease process and treatments for her patients, 
which hinders her ability to give the best nursing care possible. 
A questionnaire with a rating scale was used to ascertain the opinion of critical care 
nurses regarding their knowledge of ACS. On all questions except two (questions 4 and 
15), if a person circles a "1 or ''2", the researcher assumed that indicated the respondents 
felt they have an adequate knowledge regarding the particular aspect of ACS being 
questioned. The reverse held for questions 4 and 15~ in which case circling a "6" or "7" 
indicated the respondents felt they have an adequate knowledge. The research findings 
indicated an overall knowledge deficit regarding ACS amongst the participants. 
The analysis of the percentage of critical care nurses indicating they feel they have 
adequate knowledge and expertise regarding each individual subject area tested revealed 
that in only one area, thrombolytic agents, were over 50% of the opinion they have 
adequate knowledge. In all other subject areas, the percentages ranged from 1 to 48%, 
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reflecting that the respondents feel they have an overall knowledge deficit regarding 
ACS. 
The correlational analysis revealed that neither age nor number of years nursing 
experience had any significant effect on the scores. However, 8 of the 11 significant 
findings showed a correlation between increased number of years critical or acute care 
nursing experience and an increased perception of what the respondents feel they know. 
These findings were reflected in questions 8, 12, 14, 16, 17, 18, 19 and 20, where the p-
value was found to be equal to or less than 0.16. Questions 8, 12, 14, 16 and 17 covered, 
respectively, the factors contributing toward unstable angina, non-Q-wave and Q-wave 
MI; ST -segment and T -wave changes indicating myocardial ischemia, injury or 
infarction; the drug actions of low molecular weight heparin and the advantages and 
disadvantages of using them versus heparin; administration of GB lib/lila inhibitors to 
patients after PTCA and stent procedures; and ability to explain the rationale for use of 
GB lib/Ilia inhibitors after PTCA and stent procedures. Questions 28, 19 and 20 covered 
the subject of thrombolytic agents, their use, drug actions and potential complications. 
The level of education had a positive significant effect on 9 out of the 24 items 
questioned. Interestingly, the nurses with ADN degrees (two-year RN degree) had scores 
reflecting a perception of greater knowledge than the nurses with four-year BSN degrees. 
5.3 OUTLINE OF ACS EDUCATIONAL IN-SERVICE TRAINING SESSION 
Based on the research study findings, it is apparent that a knowledge deficit regarding 
ACS exists amongst the participating critical care nurses in this study. A four-hour in-
service training session will be presented for all critical care nurses in the hospital where 
the study was performed. Attendance will be voluntary, and continuing education credits 
will be awarded to all participants who successfully complete the class. The premise 
behind presenting this training is that formal education in critical care nursing enhances 
the knowledge and skills of nurses working in the critical care environment (Sole 
1997:58). As the nurses broaden their knowledge base regarding ACS, they will be more 
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equipped to think critically and make sound decisions within the nursing process and 
provide optimum care for their patients. Annexure VI gives an outline of a four-hour in-
service training session to be presented to critical care nurses. The information covered 
in the literature review in Chapter 2 will be utilized to present this in-service training 
session. 
5.4 LIMITATIONS OF STUDY 
5.4.1 SAMPLE SIZE 
Because of a small sample size, it was difficult to defend the validity of the findings. 
Many of the findings turned out to be nonsignificant, and it is possible that with a larger 
sample size, more of the findings would have been found to be significant. 
5.4.2 INTERNAL VALIDITY 
Internal validity was difficult to achieve. The method of distribution and collection of the 
questionnaires was not well controlled, and consequently the researcher had to assume 
that the participants did not consult outside sources of information. The small sample 
size, in contrast with the number of questionnaires distributed in nurses' mailboxes, may 
be due in part to the lack of control over the method of distribution and collection. It 
would have been more advantageous to assemble the nurses together and have them 
answer the questionnaire under supervision. 
Although validity was enhanced in a certain sense by the fact that the knowledge of the 
respondents was not actually ''tested", but that the respondents actually had to rate their 
own knowledge, it might also have had a negative side. In this situation, they did not feel 
threatened, but it cannot be said that all those rating their knowledge for example as a "1" 
or "2" would be able to score the same in a formal test. A formal test would thus had 
been a more objective instrument. 
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5.4.3 EXTERNAL VALIDITY 
External validity was also difficult to achieve. The sample size was small, which made it 
difficult to generalize the study findings to a larger population. In addition, the mean age 
and mean number of years nursing experience were fairly high (47 years and 18 years, 
respectively) and the researcher questions whether these figures accurately reflect the 
general population of critical care nurses. The convenient sample used is not 
representative of the total population. The more representative the study population is of 
the target population, the greater is the accuracy with which generalizations can be made 
from the sample to the total population (Abdellah & Levine 1979: 155). 
5.4.4 QUESTION 22 
This question was poorly worded and did not fit in with the other questions because it 
asked whether or not education was provided regularly to patients. The question did not 
provide any indication of the participants' knowledge about ACS. It should have been 
eliminated during the refinement phase before the questionnaires were printed and 
distributed. 
5.4.5 QUESTIONS 4 AND 15 
These questions were worded in such a way that adequate competency was indicated by 
circling a "6" or "7", instead of circling a "2" or "3" as in the other questions, and this 
made the analysis more complicated. It would have been easier if these two questions 
were worded so that adequate knowledge could be indicated in the same manner as in all 
the other questions. This was overlooked during the refinement phase of developing the 
questionnaire. 
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5.5 RECOMMENDATONS 
5.5.1 RECOMMENDATIONS REGARDING CRITICAL CARE NURSING 
EDUCATION 
0 Each topic covered in the literature study should be specifically included in 
curriculum for the in-service training session. 
0 The in-service training session should be given on a regular basis. Rather than 
present all the material in one training session, as is planned, cover specific topics 
on a weekly or bi-weekly basis on a on-going basis. The nurses will be more able 
to absorb the information if a smaller amount of subject material is covered 
regularly. Additionally, one can review the material covered during previous 
training sessions to ensure that the participants are actually learning the subject 
material being presented. 
5.5.2 RECOMMENDATIONS FOR CRITICAL OR ACUTE CARE NURSING 
PRACTICE 
0 Nursing care plans should be made specifically for ACS patients. This will 
ensure that there is a continuity of care from nurse to nurse, and that all aspects of 
nursing care for ACS patients are being performed. 
5.5.3 RECOMMENDATIONS FOR FURTHER RESEARCH 
0 An instrument should be developed specifically in a "test format". Such an 
instrument is more objective and is not difficult to score or analyze. 
0 A larger population should be chosen, and the study should be repeated. 
0 The instrument should be refined as suggested. 
0 A comparative study could be made between using instrument of this study and 
using a test-like instrument measuring knowledge, and then correlate the data 
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regarding the comparisons. It would be interesting to determine the correlation 
between what the respondents actually knew and how the rate their knowledge. 
5.6 SUMMARY 
The purpose of this research study was two-fold-- first, to explore and describe the 
knowledge level of critical or acute care nurses regarding acute coronary syndromes 
(ACS), and secondly, to design an in-service training on ACS for the critical care nurses 
in the hospital in which the study was performed. The results of the study revealed an 
overall knowledge deficit regarding ACS amongst the nurses participating in the study. 
Because of the small sample size, it is difficult to generalize these findings to the total 
population of critical care nurses. An in-service education training class on ACS has 
been prepared and will be offered to all critical care nurses in the hospital where the study 
was performed. This is based on the premise that formal education in critical or acute 
care nursing enhances the knowledge and skills of nurses working in the critical care 
environment. It is hoped that ·as theonurses gain knowledge and expertise in this 
particular area, they will share this knowledge with others. 
This research study was based on the premise that critical thinking is absolutely vital to 
the nursing process. Critical or acute care nursing is challenging, and critical care nurses 
should have a sound knowledge base and the ability to integrate information within the 
context in which it is gathered in order to provide the skilled and competent intensive 
care for patients whose conditionS may change rapidly. Nurses who care for ACS 
patients should know the pathophysiology of coronary artery disease and understand the 
rapidly evolving treatment options for ACS in order to provide optimum nursing care and 
be able to answer questions and provide guidance to their patients and other members of 
the heahhcare team. 
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Dear Critical Care Nurses, Annexure/ 
Enclosed you will find a questionnaire about Acute Coronary Syndromes (ACS). The 
purpose of this questionnaire is to ascertain at what level of knowledge of ACS are 
critical care nurses at UTCH at, and then analyze this data and present an in-service in 
the near future about ACS that will inform us, as nurses, about the pathophysiology of 
ACS and how we can provide optimum patient care for our patients diagnosed in this 
continuum. This data will also be presented in a dissertation on ACS that I am writing. 
Please take a few minutes to fill this questionnaire out and then put it back in the manila 
envelope labeled Acute Coronary Syndromes Questionnaire that is posted near your 
mailboxes. Please fill this out at work and do not take it home! 
For confidentiality's sake, please do not write your name on the questionnaire. Simply 
sign and date this page below, which will inform me that you have given me your 
written consent to use the questionnaire you filled out, and then detach this page and 
put both this page and your completed questionnaire in the manila envelope. 
Another reason for signing this page . . . . I would like to give you a thank you for helping 
out, and I can only do that if you sign your name! :) 
Thank you for participating in this study .... I truly appreciate your help, and hope that we 
will all learn more about this interesting subject! 
Sincerely, 
Carol Price R.N. 
NAME ____________________________ __ 
UNIT I WORK IN-------------
DATE ________________________________ _ 
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General Information: fill in the blank or circle appropriate answer 
1. Age 
2. Gender: male I female 
3. Marital status: married I single I divorced I widowed 
4. Education level: L VN I ADN I BSN I MA, MN, MSN I PhD 
5. What unit you work in: ICU I ER I OR I Cath Lab I 5 East 
6. Years experience as a nurse __ _ 
7. Years experience in critical care nursing ___ _ 
The following questions will be answered using a scale of 1- 7. 
1 = strongly agree 
2 =agree 
3 = somewhat agree 
4 = neither agree nor disagree 
5 = somewhat disagree 
6 =disagree 
7= strongly disagree 
1. I understand the definition of"Acute Coronary Syndromes" (ACS) 
1 2 3 4 5 6 7 
ANNEXURE II 
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2. I am able to explain to my patients the pathophysiology of acute coronary syndromes 
1 2 3 4 5 6 7. 
3. I am able to explain in-hospital management (including non-invasive and invasive) of 
acute coronary syndromes to my patients. 
1 2 3 4 5 6 7 
4. I would benefit from a thorough understanding of clot formation and lysis physiology. 
1 2 3 4 5 6 7 
5. I understand the pathophysiological reasons why chronic hypertension can lead to 
endothelial damage, plaque formation, plaque rupture and thrombus formation. 
1 2 3 4 5 6 7 
6. I am able to explain to my patients why chronic hypertension can lead to endothelial 
damage, plaque formation,· plaque rupture and thrombus formation. 
1 2 3 4 5 6 7 
7. I understand the difference between a Q-wave and a non-Q-wave myocardial 
infarction (Ml). 
1 2 3 4 5 6 7 
8. I understand what factors contnbute toward unstable angina and a non-Q-wave MI 
progressing to an acute MI. 
1 2 3 4 5 6 7 
9. I am familiar with cardiac markers (CPK-MB, myoglobin, Troponin I and Troponin 
T) and am able to interpret these tests correctly. 
1 2 3 4 5 6 7 
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10. I am able to explain to my patients the interpretation of cardiac markers. 
1 2 3 4 5 6 7 
11. I understand the advantages and disadvantages of each of the cardiac markers in 
diagnosing a non-Q-wave and Q-wave MI. 
1 2 3 4 5 6 7 
12. I am familiar with the ST segment and/or T-wave changes indicative of myocardial 
ischemia, injury and infarction. 
1 2 3 4 5 6 7 
13. I am experienced in sheath removal after PTCA and stent placement. 
1 2 3 4 5 6 7 
14. I understand the drug actions oflow molecular weight heparins and the 
advantages/disadvantages ofusing them verses using heparin. 
1 2 3 4 5 6 7 
15. I would benefit from learning more about glycoprotein lib/lila receptor inhibitors 
(abciximab=Reopro, eptifibatide=Integrilin, tirofiban=Aggrastat) and their use in treating 
unstable angina and non-Q-wave MI. 
1 2 3 4 5 6 7 
16. I have administered GB lib/Ilia inhibitors to patients after PTCA and PTCA/stent 
procedures and have understood the rationale for these drugs. 
1 2 3 4 5 6 7 
17. I am able to explain to my patients the rationale for using lib/lila inhibitors after 
PTCA/stent procedures. 
1 2 3 4 5 6 7 
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18. I understand the therapeutic actions and indications for thrombolytic agents 
( alteplase, anistreplase, reteplase, streptokinase, urokinase). 
1 2 3 4 5 6 7 
19. I have a thorough knowledge of, and am able to recognize, potential complications 
that can occur with patients receiving thrombolytic agents. 
1 2 3 4 5 6 7 
20. I am aware of the contraindications to administering thrombolytic agents and/or GB 
lib/lila inhibitors. 
1 2 3 4 5 6 7 
21. I understand the rationale behind administering beta-blockers for patients who have 
recently undergone a non-Q-wave or Q-wave MI. 
1 2 3 4 5 6 7 
22. I regularly provide patient education regarding disease pathophysiology and drug 
actions and their side effects to my patients diagnosed with unstable angina, non-Q-wave 
and Q-wave MI. 
1 2 3 4 5 6 7 
23. I understand the drug actions and use for the following medications used for patients 
discharged from the hospital: calcium channel blockers, long-acting nitrates, beta 
blockers, angiotension-converting enzyme (ACE) inhibitors, ASA, clopidogul, 
ticlopidine, and warfarin. 
1 2 3 4 5 6 7 
24. I am able to explain to my patients before they are discharged the uses and side 
effects of the drugs listed in question# 23. 
1 2 3 4 5 6 7 
April 17, 2000 
Ms. Anne DeWitt, RN, MSN 
Nurse Executive 
University of Texas Health Center 
11937 US Highway 271 
Tyler, TX 75708-3154 
Dear Anne, 
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ANNEXURE III 
Carol G. Price R.N. 
P.O. Box 1400 
Van, TX 75790 
tel. (903) 963-3267 
email: xwam@writeme. com 
I am in the process of writing my dissertation oflimited scope for my Master's degree in 
Advanced Clinical Nursing through the University of South Africa. Part of the 
requirement for this degree is that I conduct a research study. I am writing to ask your 
permission to conduct this research study at UTHC. 
I would like to do a research study at UTHC to explore and describe the knowledge of 
critical care nurses regarding Acute Coronary Syndromes (ACS). The title of the research 
is: THE KNOWLEDGE OF CRITICAL CARE NURSES REGARDING ACUTE 
CORONARY SYNDROMES. The study will involve the use of a questionnaire to 
ascertain the nurses' knowledge level regarding ACS. Enclosed you will find a copy of 
the questionnaire. 
Participation in this study will be voluntary for critical care nurses working in ICU, OR, 
ER, cardiac cath lab and 5-East (Telemetry). As you can see from the cover letter to the 
nurses, anonymity and confidentiality will be ensured, and informed consent forms are 
signed by all participants. 
One of my purposes in this study is to prepare an in-service training class on ACS once I 
have ascertained the knowledge level regarding ACS amongst the nurses. 
Would you please look over the questionnaire, let me know ifthere are any changes you 
would recommend, let me know if it is alright ifi proceed with this research study, using 
this questionnaire? 
Thank you so much! 
Sincerely, 
Carol Price R.N. 
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AnnexureW 
Correlational Analysis 
Critical 
Nurse Care 
Question Age Experience Experience 
Total Correlation .0560 -.0180 -.3134 
Sample Size 17 19 19 
Probability ns ns ns 
01 Correlation .0737 -.1047 -.0671 
Sample Size 21 24 24 
Probability ns ns ns 
Q2 Correlation .0875 .1258 -.1632 
Sample Size 21 24 24 
Probability ns ns ns 
03 Correlation .1073 .0994 -.0646 
Sample Size 21 24 24 
Probability ns ns ns 
04 Correlation .3590 -.0068 -.0436 
Sample Size 21 24 24 
Probability p = .11 ns ns 
05 Correlation .2665 -.0139 -.2187 
Sample Size 21 24 24 
Probability ns ns ns 
Q6 Correlation .2305 -.0483 -.2574 
Sample Size 20 23 23 
Probability ns ns ns 
07 Correlation -.0553 .0385 -.2000 
Sample Size 21 24 24 
Probability ns ns ns 
08 Correlation -.0238 -.2583 -.3285 
Sample Size 21 24 24 
Probability ns ns p = .12 
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Correlational Analysis 
(cont) 
Critical 
Nurse Care 
Question Age Experience Experience 
09 Correlation -.0763 -.1797 -.1888 
Sample Size 21 24 24 
Probability ns ns ns 
010 Correlation .2208 .1387 -.1705 
Sample Size 21 24 24 
Probability ns ns ns 
011 Correlation -.2117 -.2067 -.2796 
Sample Size 21 24 24 
Probability ns ns ns 
012 Correlation -.1334 .1321 -.3093 
Sample Size 21 24 24 
Probability ns ns p = .14 
013 Correlation .1406 .0537 -.2258 
Sample Size 21 24 24 
Probability ns ns ns 
014 Correlation -.3138 -.2349 -.3404 
Sample Size 21 24 24 
Probability p= .16 ns p = .10 
015 Correlation .2387 .0735 -.0906 
Sample Size 21 24 24 
Probability ns ns ns 
016 Correlation -.1000 .0367 -.3543 
Sample Size 20 23 23 
Probability ns ns p= .10 
017 Correlation -.1407 -.0435 -.3533 
Sample Size 20 23 23 
Probability ns ns p= .10 
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Correlational Analysis 
(cont) 
Critical 
Nurse Care 
Question Age Experience Experience 
018 Correlation -.1326 -.2123 -.3459 
Sample Size 21 23 23 
Probability ns ns p = .11 
019 Correlation -.1303 -.3182 -.5465 
Sample Size 21 23 23 
Probability ns p = .14 p < .01 
020 Correlation -.2170 -.1805 -.4186 
Sample Size 21 23 23 
Probability ns ns p< .05 
021 Correlation .0304 .2613 -.2553 
Sample Size 21 23 23 
Probability ns ns ns 
022 Correlation .2023 .3103 -.0177 
Sample Size 20 22 22 
Probability ns p= .16 ns 
023 Correlation .. 1906' .1647 -.0319 
Sample Size 19 21 21 
Probability ns ns ns 
024 Correlation .1372 .0679 -.0841 
Sample Size 20 22 22 
Probability ns ns ns 
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Annexure V 
Effect of Education Level on the Total Scale and Individual Questions 
Sample 
Question Level Size Mean (sci) F-value p-value 
Total ADN 11 65.44 (16.88) 2.81 p= .12 
BSN/Masters 8 82.40 (20.37) 
Q1 ADN 11 2.82 (1.08) 2.61 p= .12 
BSN/Masters 8 2.13 (0.64) 
Q2 ADN 11 2.73 (1.10) 0.29 ns 
BSN/Masters 8 2.50 (0.63) 
Q3 ADN 11 2.55 (1.13) 0.20 ns 
BSN/Masters 8 2.75 (0.71) 
Q4 ADN 11 1.91 (1.04) 0.01 ns 
BSN/Masters 8 1.88 (0.83) 
Q5 ADN 11 2.91 (1.38) 0.99 ns 
BSN/Masters 8 2.38 (0.74) 
Q6 ADN 11 2.91 (1.38) 0.01 ns 
BSN/Masters 7 2.86 (0.90) 
Q7 ADN 11 3.00 (1.34) 0.99 ns 
BSN/Masters 8 3.25 (1.28) 
Q8 ADN 11 3.18 (1.33) 0.14 ns 
BSN/Masters 8 3.38 (0.74) 
Q9 ADN 11 2.73 (1.68) 0.03 ns 
BSN/Masters 8 2.63 (0.52) 
Q10 ADN 11 2.36 (0.92) 2.19 p = .16 
BSN/Masters 8 3.00 (0.93) 
Q11 ADN 11 3.82 (0.98) 0.58 ns 
BSN/Masters 8 3.50 (0.76) 
Q12 ADN 11 2.45 (0.82) 0.02 ns 
BSN/Masters 8 2.50 (0.76) 
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Effect of Education Level on the Total Scale and Individual Questions 
(cont) 
Sample 
Question Level Size Mean (sd) F-value p-value 
Q13 ADN 11 2.73 (2.20) 4.37 p< .05 
BSN/Masters 8 4.88 (2.23) 
Q14 ADN 11 2.91 (1.38) 3.24 p= .09 
BSN/Masters 8 4.00 (1.20) 
Q15 ADN 11 2.45 (1.04) 0.16 ns 
BSN/Masters 8 2.75 (2.12) 
Q16 ADN 10 2.90 (1.29) 7.51 p< .05 
BSN/Masters 8 4.75 (1.58) 
Q17 ADN 10 3.10 (1.20) 5.63 p< .05 
BSN/Masters 8 4.88 (1.96) 
Q18 ADN 11 2.64 (0.81) 0.14 ns 
BSN/Masters 7 2.86 (1.68) 
Q19 ADN 11 2.09 (1.14) 0.64 ns 
BSN/Masters 7 2.57 (1.40) 
Q20 ADN 11 2.18 (1.08) 1.45 ns 
BSN/Masters 7 3.00 (1.83) 
021 ADN 11 3.18 (1.25) 0.15 ns 
BSN/Masters 7 3.43 (1.40) 
Q22 ADN 11 3.18 (0.60) 5.90 p< .05 
BSN/Masters 6 4.50 (1.64) 
Q23 ADN 10 3.00 (1.15) 4.38 p= .06 
BSN/Masters 6 4.33 (1.37) 
Q24 ADN 11 3.00 (1.10) 4.85 p< .05 
BSN/Masters 6 4.33 (1.37) 
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ANNEXURE VI 
OUTLINE OF IN-SERVICE TRAINING SESSION ON ACS 
1. Define Acute Coronary Syndromes (ACS) A. Define: 
1. Unstable angina 
2. Non-Q-wave Ml 
3. Q-wave Ml 
2. Correlate the process in the clotting A. Factors triggering initiation of process-
cascade, where thrombus formation occurs, extrinsic and intrinsic. 
and at which point in the clotting cascade B. Mechanisms of platelet aggregation and 
specific medications exert their affects. platelet plug. 
C. Thrombus formation. 
D. Clotting cascade and thrombus formation. 
E. Pharmacologic agents interfering in 
thrombus formation. 
1. Aspirin 
2. Second-generation platelet inhibitors: 
ticlopidine and clopidogrel (Ticlid & Plavix). 
4. GP lib/lila inhibitors 
5. Heparin 
6. Low molecular weight heparins 
3. Describe the physiology, including results of A. Physiology of the endothelium. 
damage, of the endothelium. B. Factors involved with endothelium damage. 
c. Results of damage. 
4. Correlate endothelium damage to ACS. A. Endothelium damage sequelae. 
B. Treatment with ACE inhibitors. 
5. Explain the process of coronary artery A. Mechanism of plaque formation. 
plaque formation 1. Serum lipids 
2. Fatty streaks 
3. Monocytes 
4. Macrophages and foam cells 
B. Lipid core formation. 
97 
C. Fibrous cap stabilization. 
D. Occlusion 
1. Partial 
2. Total 
6. Correlate the mechanisms of plaque rupture A. Mechanisms of plaque rupture. 
and ACS. B. Plaque rupture sequelae 
7. Identify specific ECG changes in unstable 
angina, non-0-wave Ml and Q-wave MI. 
8. Describe the measurement, advantage and 
disadvantage of each of the three most 
commonly used cardiac markers. Include 
normal and abnormal values. 
9. Compare and contrast the various drugs 
used in the treatment of ACS including 
mechanisms of action, side effects and nursing 
actions. 
10. Correlate rationale for current ACS 
treatments with the knowledge of 
pathophysiology related to ACS. 
11. Compare the UTHC protocols for chest 
pain, acute Ml and/or ACS to current medical 
treatment guidelines. 
12. Acknowledge ongoing research and their 
possible implications in future treatment of 
ACS. 
1. Ischemia 
2. Non-Q-wave Ml 
3. Q-waveMI 
C. Use of statins. 
A. Q-wave 
B. ST -segment elevation or depression 
C. T-wave 
A Myoglobin 
B. CK-MB 
C. Troponins (I and T) 
A Morphine sulfate 
B. Nitrates 
C. Beta-blockers 
D. Calcium-channel blockers 
E. ACE inhibitors 
F. Thrombolytics 
A. Diagnostic: angiography. 
B. Interventions I Procedures: PCI, FPCI 
C. Pharmacologic 
A. Chest Pain Rapid Evaluation Pathway I 
Protocol 
B. ACS Pathway I Protocol 
A Current research 
1. Projects 
2. Future predictions 
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